Search criteria | ||||
High‑Expenditure Disease in the EU‑28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes? | ||||
Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck | ||||
Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium | ||||
PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4 |
||||
, Article | ||||
, Europe | ||||
Abstract: https://link.springer.com/epdf/10.1007/s41669-020-00253-4?sharing_token=k4IP2sUMn4HrAsHs0WBqlPe4RwlQNchNByi7wbcMAY4Tirkz8MqaNXdxznG7LjXgeeOE1lL_TUFtfOXdhNB_IQ05wAS6SyWtTgC3QV4GkZ1V3rKbHAI_lwyKV2fZ5OfrjVrTPTsYaJr4E7ZctQaMI_Yhmg_dNtoFcG1705dWSU4%3D | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics, Oncology | 2021 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review | |
Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation | ||||
Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY | ||||
From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Real‐World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.). | ||||
Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ahajournals.org/doi/10.1161/JAHA.119.014347 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Medication compliance | 2020 | English | , Epidemiological study | |
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study | ||||
Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain | ||||
IPVC, Barcelona, Spain, 23-27 March 2020 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2020 | English | , Burden of illness, Observational study, Retrospective Field Study | |
Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals | ||||
Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, Díaz-Regañón J6, López D6, Lozano V6, Gómez-Ulloa D7, Fenoll R7, Sánchez E7, McCann E8 | ||||
1 Vall d'Hebron University Hospital, Barcelona, Spain 2 Marqués de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La Coruña University Hospital, La Coruña, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Real-world treatment patterns observed in patients with carbapenem-resistant Gram-negative infections in Italian hospitals | ||||
Durante Mangoni E1, Mastroianni C2, Viale P3, Bassetti M4, Citton R5, Fenoll R6, Roset M6, McCann E7 | ||||
1 University of Campania ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 2 Policlinico Umberto I, Rome, Italy 3 AOU Policlinico S. Orsola-Malpighi, Bologna, Italy 4 University of Genova and Ospedale Policlinico San Martino, Genova, Italy 5 RC Merck Sharp & Dohme, Rome, Italy 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals | ||||
Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, Sánchez E7, McCann E8 | ||||
1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Greece | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals | ||||
Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17 | ||||
1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Greece, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals | ||||
Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17 | ||||
1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Greece, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France | ||||
Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4 | ||||
1 Sorbonne Université, medical oncology department, AP-HP, hôpital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France | ||||
ESMO GI, Barcelona, Spain 1-4 July 2020 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study, Retrospective Field Study | |
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer | ||||
Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7 | ||||
1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy | ||||
BMC Gastroenterology BMC Gastroenterology volume 20, Article number: 133 (2020) |
||||
, Article | ||||
, Australia, Canada, Italy, UK | ||||
Abstract: https://doi.org/10.1186/s12876-020-01232-z | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective cohort analysis | |
Nivolumab-treated non-small cell lung cancer patients in the United Kingdom | ||||
Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5 | ||||
1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US | ||||
BMC Gastroenterology |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study, Retrospective Field Study | |
Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge | ||||
Si L, Willis MS, Asseburg C, Tew M, Clarke PM, Lamotte M, Ramos M, Hui S, Shi L, Zhang P, McEwan P, Ye W, Herman WH, Isaman DJ, Kuo S, Schramm W, Sailer F, Brennan A, Pollard D, Smolen HJ, Leal J, Gray A, Patel R, Feenstra T, Palmer AJ | ||||
IQVIA, Zaventem, Belgium and IQVIA, Lisbon, Portugal | ||||
Value in Health |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Cost effectiveness | |
Contrasting three type 2 diabetes cardiovascular risk equations for east asia with ukpds82 using the IQVIA core diabetes model | ||||
Ramos M1, Monteiro S2, Olivieri AV3, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK 3 IQVIA, Basel, Switzerland | ||||
ISPOR US 2020 Orlando, Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56 |
||||
, Article | ||||
, Asia Pacific | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Population Based Study | |
Impact of using different types of hba1c progression in the IQVIA core diabetes model | ||||
Ramos M1, Monteiro S2, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK | ||||
ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Population Based Study | |
Does including acute pancreatitis as a complication have an impact on cost-effectiveness analyses using the IQVIA core diabetes model? | ||||
Monteiro S1, Ramos M2, Lamotte M2 | ||||
1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium | ||||
ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Population Based Study | |
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results | ||||
Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8 | ||||
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands | ||||
European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020 |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Public Health | 2020 | English | , Population Based Study, Public Health, Retrospective database analysis | |
Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study. | ||||
Ishii H 1, Shuichi S 2, Williams P 3, Demiya S 4, Aranishi T 2, Treuer T 5. | ||||
1 Department of Diabetology, Nara Medical University, Nara, Japan. 2 Eli Lilly Japan, K.K., Kobe, Japan. 3 RWE Patient-Centered Endpoints Center of Excellence, IQVIA, Paris, France. Electronic address: Paul.Williams@iqvia.com. 4 IQVIA Solutions K.K., Tokyo Japan. 5 Eli Lilly and Company, Budapest, Hungary. | ||||
Diabetes Res Clin Pract. |
||||
, Article | ||||
, Japan | ||||
Abstract: DOI: 10.1016/j.diabres.2020.108076 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Patient questionnaire | |
Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach | ||||
Guilherme Silva Julian 1, Ricardo Papaléo Rosim 2, Estela Cristina Carneseca 3, Jéssica Rigolon 2 | ||||
1 IQVIA Brasil, São Paulo-SP, Brazil. 2 Biogen Brasil, São Paulo-SP, Brazil. 3 Proestat Consultoria Estatística, Ribeirão Preto-SP, Brazil. | ||||
PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768 |
||||
, Article | ||||
, Brazil | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32119696/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective database analysis | |
Cost of Macrovascular Complications in People With Diabetes From a Public Healthcare Perspective: A Retrospective Database Study in Brazil | ||||
Guilherme Silva Julian 1, Daniel Campos 1, Julie Broe Honore 2, Flávia Sauer Tobaruella 3, Jung Hyun Yoon 3, Nino Hallén 2 | ||||
1 IQVIA Brasil, São Paulo, Brazil. 2 Novo Nordisk A/S, Søborg, Denmark. 3 Novo Nordisk Farmacêutica Do Brasil Ltda, São Paulo, Brazil. | ||||
PMID: 32372710 DOI: 10.1080/13696998.2020.1764966 |
||||
, Article | ||||
, Brazil | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1764966 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Observational study, Retrospective database analysis | |
Concomitant use of drugs known to cause interactions with oral antiplatelets—polypharmacy in acute coronary syndrome outpatients in Finland | ||||
Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen, Ville Kytö | ||||
Ville Kytö: Heart Center, Turku University Hospital | ||||
European Journal of Clinical Pharmacology (2020) 76:257–265 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://link.springer.com/article/10.1007/s00228-019-02777-z | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2020 | English | , Population Based Study, Retrospective database analysis | |
Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study | ||||
Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F | ||||
Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelli”, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy | ||||
Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2020 | English | , Epidemiological study, Retrospective database analysis | |
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis | ||||
Lavorini F, Bianco A, Blasi F, Braido F, Corsico AG, Di Marco F, Gentile A, Paggiaro PL, Pegoraro V, Pelaia G, Rogliani P, Santus P, Scichilone N, Soldi A, Canonica GW | ||||
Lavorini F: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. | ||||
Respir Med. 2020;166:105937. doi:10.1016/j.rmed.2020.105937 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S0954611120300779 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2020 | English | , Retrospective database analysis, Survey research | |
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study | ||||
Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi | ||||
a The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA b Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA c The Walton Centre, Liverpool, UK d University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany e Parkinson-Klinik Ortenau, Wolfach, Germany f Allergan, an AbbVie Company, Irvine, CA, USA g IQVIA Real-World Evidence Solutions, Cambridge, MA, USA h MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA | ||||
PM R . 2020 Jan 17. doi: 10.1002/pmrj.12328. PMID: 31953896 DOI: 10.1002/pmrj.12328 |
||||
, Article | ||||
, Asia Pacific, Europe, USA | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2590171020300187?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Medication compliance | 2020 | English | , Methodology, Observational study | |
Predicting hospitalization of Swedish patients due to COPD exacerbation with machine learning | ||||
Karin Lisspers, Uppsala University Christer Janson, Uppsala University Gunnar Johansson, Uppsala University Kjell Larsson, Karolinska Institutet Björn Ställberg, Uppsala University Mario Mueller, IQVIA Mateusz Luczko, IQVIA Bine Kjoeller Bjerregaard, IQVIA Stuart Fell, IQVIA Gerald Bacher, Novartis Bjorn Holzhauer, Novartis Pankaj Goyal, Novartis Pharma AG | ||||
Uppsala University, IQVIA Denmark, IQVIA Germany, IQVIA Poland | ||||
IPCRG, International Primary Care Respiratory Group Conference 2020 |
||||
, Oral presentation | ||||
, Sweden | ||||
Abstract: https://www.ipcrg.org/11516 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2020 | English | ||
Évaluation de la population à risque d’hyperkaliémie | ||||
Gilles Berrut1 Anne-Sophie Boureau1 Laure de Decker1 Olivier Hanon2 | ||||
1 Pôle hospitalo-universitaire de gérontologie clinique, CHU Nantes, France 2 Hôpitaux universitaires Paris Centre, Service de gériatrie, Hôpital Broca, Université Paris-Descartes, Paris, France | ||||
10.1684/pnv.2020.0873 |
||||
, Article | ||||
Abstract: https://www.jle.com/fr/revues/gpn/e-docs/evaluation_de_la_population_a_risque_dhyperkaliemie__317258/article.phtml | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Hematology | 2020 | French | , Retrospective database analysis | |
Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions. | ||||
Masaya H, Kenji H, Masafumi O, Ainiwaer D, Masaaki I, Takeshi A | ||||
IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
ISPOR Asia Pacific 2020 Conference |
||||
, Abstract | ||||
, Japan | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , De-identification / anonymisation | |
Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan | ||||
Iguch.T1, Nakamura.Y2, Akiyama.T3, Krishant C3, Yu E3 | ||||
1 Osaka City University Graduate School of Medicine Urology and Pathology, 2 Bayer Yakuhin Co., Ltd. Market Access Headquarters, 3 IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions | ||||
Accepted Presentation Japanese Urological Association 2020 |
||||
, Abstract | ||||
, Japan | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Survey research | |
A SYSTEMATIC LITERATURE REVIEW OF THE DISEASE AND ECONOMIC BURDEN OF MULTIDRUG RESISTANCE GRAM NEGATIVE INFECTIONS (MRGN) IN JAPAN. | ||||
Hara, T1. Tawseef, A2, Mitsuo, R2 | ||||
1. SHIONOGI Personnel; 2. IQVIA Solutions Japan K.K. | ||||
ISPOR 2020 Asia |
||||
, Abstract | ||||
, Japan | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2020 | English | , Burden of illness, Review | |
Retrospective Study for Comorbidities in ACTIVE Population Using Japanese Health Insurance Claims Database | ||||
Seok-Won Kim, Ayumi Morishita, Takeshi Akiyama | ||||
Real World Evidence Solutions, IQVIA Solutions Japan K.K. | ||||
ISPOR Asia Pacific 2020 Conference |
||||
, Abstract | ||||
, Japan | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , Database Study | |
Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma | ||||
Masakazu Yamada 1 , Tadashi Nakano 2 , Hiroyuki Matsuda 3 , Seok-Won Kim 3 , Yasutaka Takagi 4 | ||||
1Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan. 2Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan. 3Real World Evidence Solutions, IQVIA solutions Japan, Tokyo, Japan. 4Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd. Osaka, Japan. | ||||
Journal medical economics |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1804392 | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2020 | English | , Budget impact, Cost effectiveness | |
Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan | ||||
Toyomi Kamesaki 1 , Jun-Ichi Nishimura 2 , Hideho Wada 3 , Eric Yu 4 , Elisa Tsao 5 , Jaime Morales 5 , Yuzuru Kanakura 2 6 | ||||
1 Division of Support in Community Medicine, Center for Community Medicine, Regional Medical Center, Center for Regional Medical Care, Jichi Medical University, 3311 - 1 Yakushiji Shimotsuke-shi, Tochigi, Japan. kmskt@jicji.ac.jp. 2 Osaka University, Osaka, Japan. 3 Kawasaki Medical School, Kurashiki, Japan. 4 IQVIA Solutions K.K., Tokyo, Japan. 5 Sanofi, Waltham, MA, USA. 6 Sumitomo Hospital, Osaka, Japan. | ||||
International journal of hematology |
||||
, Article | ||||
, Japan | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32608010/ | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2020 | English | , Retrospective database analysis | |
Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling | ||||
Akihito Uda, MPH,* Yuki Eto, MSc,* Yuxin Li, MSc,† Hiroyuki Matsuda, MSc,‡ Sven Demiya, PhD, MBA,‡ Tomoyuki Watanabe, PhD,* Mihoko Ota, MMA,* Ryuichi Iwakiri, MD, PhD,* and Ataru Igarashi, PhD,§,‖ | ||||
*Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan; †IQVIA Solutions UK Ltd., London, UK; ‡IQVIA Solutions Japan KK, Tokyo, Japan; §Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan; ‖Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan | ||||
Crohn's & Colitis 360 |
||||
, Article | ||||
, Japan | ||||
Abstract: https://academic.oup.com/crohnscolitis360/article/2/2/otaa017/5809344 | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2020 | English | , Budget impact, Cost effectiveness, Economic evaluation | |
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany | ||||
Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4 | ||||
1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain | ||||
Postgraduate Medicine |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Compliance | |
Who owns patient data? The answer is not that simple | ||||
Alison Bourke, Georgina Bourke | ||||
Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI. | ||||
BJMOpinion August 6, 2020 |
||||
, Article | ||||
, UK, USA | ||||
Abstract: https://blogs.bmj.com/bmj/2020/08/06/who-owns-patient-data-the-answer-is-not-that-simple/ | ||||
Condition | Year | Language | Analysis type | |
, COVID-19, Health policy | 2020 | English | , Market impact | |
Infections in patients with multiple sclerosis: A national cohort study in Sweden | ||||
Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery | ||||
1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA | ||||
Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23]. |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32736217/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods | 2020 | English | , Epidemiological study | |
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden | ||||
Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery | ||||
1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA | ||||
Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32864156/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods | 2020 | English | , Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis | |
Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions | ||||
Kristin M Sheffield , Nancy A Dreyer , James F Murray, Douglas E Faries & Megan N Klopchin | ||||
1Global Patient Outcomes & Real World Evidence, Eli Lilly & Company, Indianapolis, IN 46225, USA 2IQVIA Real-World & Analytic Solutions, Cambridge, MA 02139, USA 3Real World Analytics, Eli Lilly & Company, Indianapolis, IN 46225, USA | ||||
Published Online:11 Sep 2020https://doi.org/10.2217/cer-2020-0161 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2020-0161 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study, Guidelines, Methodology, Public Health | 2020 | English | , Methodology, Observational study, Population Based Study | |
Combatting COVID-19 With Real-World Evidence | ||||
Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD | ||||
Jennifer B. Christian, PharmD, MPH, PhD, is vice president of Clinical Evidence & Epidemiology, Real World Solutions, IQVIA Matthew W. Reynolds, PhD, is vice president, Real World Evidence, IQVIA | ||||
AJMC.org (UVPM: 137,786) September 7, 2020 Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/view/combatting-covid-19-with-real-world-evidence | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Burden of illness, direct to patient research, Methodology | |
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | ||||
Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group | ||||
* Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia | ||||
Endocrinology, Diabetes and Metabolism 2020;00:e00183 |
||||
, Article | ||||
, Japan, South Korea, Taiwan | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/edm2.183 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2020 | English | , Epidemiological study, Retrospective database analysis | |
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany | ||||
Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4 | ||||
1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain | ||||
Postgraduate Medicine |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2020 | English | , Compliance | |
Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden | ||||
Itälä-Remes M1, Viayna E2, Nicklasson M3, Keränen M4, Thunström D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5 | ||||
1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland | ||||
ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy |
||||
, Poster | ||||
, Finland, Sweden | ||||
Abstract: x | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Transplant | 2020 | English | , Population Based Study, Retrospective cohort analysis | |
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study | ||||
Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D’Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5 | ||||
1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy | ||||
COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020 |
||||
, Poster | ||||
, Canada, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2020 | English | , Population Based Study | |
Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue | ||||
Brad Millson, G Sarah Power, Dr. Roger S. McIntyre | ||||
Brad Millson, G Sarah Power, IQVIA RWE team | ||||
CADTH 2020 |
||||
, Article | ||||
, Canada | ||||
Abstract: hhttps://www.sciencedirect.com/science/article/pii/S0165032720324903 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Mental health | 2020 | English | , Retrospective cohort analysis | |
Osteoporosis and fracture risk associated with ICS use among Swedish COPD patients: the ARCTIC study | ||||
Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen, Kjell Larsson | ||||
1Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Institutes for Biomedical Research (NIBR), Cambridge, USA and Basel, Switzerland; 5IQVIA Solutions, Copenhagen, Denmark; 6Intergrative Toxicology, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden | ||||
Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.00515-2020). |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://erj.ersjournals.com/content/early/2020/08/28/13993003.00515-2020 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2020 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients | ||||
Björn Ställberg 1✉, Christer Janson2, Karin Lisspers1, Gunnar Johansson1, Florian S. Gutzwiller 3, Karen Mezzi3, Bine Kjoeller Bjerregaard 4, Anne Mette Tranberg Kejs4, Leif Jorgensen4 and Kjell Larsson5 | ||||
1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 3Novartis Pharma AG, Basel, Switzerland. 4IQVIA Solutions, Copenhagen, Denmark. 5Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. ?email: b.stallberg@telia.com | ||||
npj Primary Care Respiratory Medicine (2020) 30:47 ; https://doi.org/10.1038/s41533-020-00207-7 |
||||
, Article | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2020 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries | ||||
Akira Yuasa 1,2, Naohiro Yonemoto 1, Sven Demiya 3, Chihiro Foellscher 3, Shunya Ikeda 2 | ||||
1 Pfizer Japan Inc, Tokyo, Japan 2 Graduate School of Medicine, International University of Health and Welfare, 1-26, Akasaka 4-chome, Minato-ku, Tokyo, 107-8402, Japan 3 IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
PharmacoEconomics - Open |
||||
, Article | ||||
, Japan | ||||
Abstract: https://link.springer.com/article/10.1007/s41669-020-00235-6#Abs1 | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2020 | English | , Economic evaluation | |
A Retrospective Observational Cohort study to Assess the Prevalence of Diabetic Kidney Disease Among Type 2 Diabetes Patients in Ontario, Canada | ||||
Wally Rapattoni, David Zante, Ali Tehrani, Varun Myageri, Shane Golden, Brad Millson, Sheldon W. Tobe, Jennifer B. Rose | ||||
Ali Tehrai, Varun Myageri, shane Golden, Brad Millson | ||||
ERA - EDRA Virtual Congress June 6-9 2020 |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://academic.oup.com/ndt/article/35/Supplement_3/gfaa142.P0775/5853053 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Public Health | 2020 | English | , Clinical setting: hospital, Clinical setting: Primary care, Cost analysis, direct-to-patient research, Observational study, Retrospective cohort analysis | |
Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan | ||||
Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2*, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 | ||||
1 Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan 2 Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan 3 IQVIA Solutions Japan K.K., Tokyo, Japan 4 IQVIA UK, London, UK * corresponding author | ||||
Journal of Medical Economics |
||||
, Article | ||||
, Japan | ||||
Abstract: TBD | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2020 | English | , Budget impact | |
Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal | ||||
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung, Andreas Karabis | ||||
IQVIA, 210 Pentonville Road, London, N1 9JY; IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, Netherlands; Department of Statistical Science, University College London, London, WC1E 6BT, UK. | ||||
, Article | ||||
Abstract: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01241-4 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Rare Diseases | 2020 | English | , Literature Review, Review | |
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee | ||||
Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1 | ||||
1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom | ||||
First published: 18 January 2020 https://doi.org/10.1002/cpt.1775 |
||||
, Abstract, Article | ||||
, France, Germany, UK | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Health policy | 2020 | English | , Retrospective database analysis | |
Interventional or Non-Interventional? Analyzing the Differences Between Clinical Studies Using Medicines in the European Union | ||||
Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc | ||||
Clinical Researcher February 11, 2020 Clinical Trial Regulation (EU) No. 536/2014 (REG 536/2014 |
||||
, Article, Online article | ||||
, Europe | ||||
Abstract: https://acrpnet.org/2020/02/11/interventional-or-non-interventional-analyzing-the-differences-between-clinical-studies-using-medicines-in-the-european-union/ | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2020 | English | , Population Based Study, Retrospective database analysis | |
Modernizing Regulatory Evidence with Trials and Real-World Studies | ||||
Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5 |
||||
, Article | ||||
, USA | ||||
Abstract: https://link.springer.com/article/10.1007%2Fs43441-020-00131-5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective database analysis | |
Projected long-term clinical benefit and cost-effectiveness of empagliflozin compared to glimepiride in patients with type 2 diabetes in China | ||||
Lamotte M1, Salem A2, Mettam S2, Ustyugova A2, Zhang YJ3, Ramos M1 | ||||
1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International, GmbH, Germany 3 Boehringer Ingelheim, Beijing, China | ||||
ADA, San Francisco, US, 07-11 June 2019 |
||||
, Poster | ||||
, China | ||||
Abstract: https://doi.org/10.2337/db19-1292-P | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Contrasting Framingham Risk Equations in Type 2 Diabetes Using the IQVIA Core Diabetes Model | ||||
Monteiro S1, Ramos M2, Altrabsheh E1, Gurjar K3, Olivieri A4, Lamotte M2 | ||||
1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium 3 IQVIA, Gurgaon, India 4 IQVIA, Basel, Switzerland | ||||
ISPOR, New Orleans, 18-22 May 2019 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.04.585 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Contrasting three type 2 diabetes cardiovascular risk equations for East Asia with UKPDS82 using the IQIVA core diabetes model | ||||
Olivieri A1, Ramos M2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M2 | ||||
1 IQVIA, Basel, Switzerland 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India | ||||
ISPOR, New Orleans, 18-22 May 2019 |
||||
, Poster | ||||
, China | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Body mass index associated utility approaches in the IQVIA core diabetes model | ||||
Ramos M1, Olivieri A2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 IQVIA, Basel, Switzerland 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India | ||||
ISPOR, New Orleans, 18-22 May 2019 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.04.573 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Comparability of results using two alternative versions of the IQVIA CORE Diabetes Model | ||||
Gurjar K1, Ramos M2, Monteiro S3, Altrabsheh E3, Olivieri A4, Lamotte M2 | ||||
1 IQVIA, Gurgaon, India 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Basel, Switzerland | ||||
ISPOR, New Orleans, 18-22 May 2019 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.04.580 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Association Between Cardiovascular Disease Risk Factors and Hypoglycaemic events in Type 2 Diabetes Using the IQVIA Core Diabetes Model | ||||
Altrabsheh E1, Monteiro S1, Ramos M2, Gurjar K3, Olivieri A4, Lamotte M2 | ||||
1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium 3 IQVIA, Gurgaon, India 4 IQVIA, Basel, Switzerland | ||||
ISPOR, New Orleans, 18-22 May 2019 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.04.613 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Cost effectiveness, Population Based Study | |
Real-world treatment patterns of patients diagnosed with complicated urinary tract infections, complicated intra-abdominal infections, and hospital acquired and ventilator-associated bacterial pneumonia attributable to carbapenem-resistant Gram-negative bacilli in Spain | ||||
Ferrer R1, Fariñas MC2, Bou Arevalo G3, Maseda E4, Salavert M5, Gómez Ulloa D6, Fenoll R6, Sánchez E6, Doshi I7, Diaz-Regañon J8, Mccann E7 | ||||
1 Hospital Universitari Vall d’Hebron, Barcelona, Spain 2 Hospital Marqués de Valdecilla, Santander, Spain 3 Hospital Universitario A Coruña, La Coruña, Spain 4 Hospital Universitario La Paz, Madrid, Spain 5 Hospital Universitario y Politécnico La Fe, Valencia, Spain 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US 8 Merck Sharp & Dohme Corp., Madrid, Spain | ||||
ECCMID, Amsterdam, Netherlands, 13-16 April 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2019 | English | , Observational study, Retrospective database analysis | |
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in a Prefilled Pen in Germany | ||||
Chen J1, Perez-Nieves M1, Piras De Oliveira C1, Spaepen E2, Osumili B3, Ling Poon J1, Schloot N2, Lara N4, Garcia Alvarez L4, Roset M4, Lennartz D5 | ||||
1 Lilly and Company, Indianapolis, US 2 Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Barcelona, Spain 5 IQVIA, Munich, Germany | ||||
ECE, Lyon, France, 18-21 May 2019 |
||||
, Poster | ||||
, Germany | ||||
Abstract: htpps://doi.org/10.1530/endoabs.63.P207 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2019 | English | , Survey research | |
Health economic effects of the updated foot ulcer submodel | ||||
Monteiro S1, Ramos M2, Lamotte M2 | ||||
1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.899 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness | |
The clinical and economic impact of adding an adherence module to the IQVIAcore diabetes model | ||||
Ramos M1, Monteiro S2, Altrabsheh E2, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
, Germany | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.943 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness, Survey research | |
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up | ||||
Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7 | ||||
1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain | ||||
Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | Spanish | , Population Based Study, Survey research | |
The cost effectiveness of Enoxaparin in the previon of venous thromboembolism in patients undergoing major surgery in Egypt | ||||
Farag A1, Abdel Moety H1, Hassan L2, Pathak P3, Lamotte M4, Levorsen A5 | ||||
1 Cairo University, Cairo, Egypt 2 Alexandria University, Alexandria, Egypt 3 IQVIA, Dubai, United Arab Emirates 4 IQVIA, Zaventem, Belgium 5 Sanofi, Global, France | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
, Egypt | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.2604 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Orthopedics | 2019 | English | , Cost effectiveness | |
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients | ||||
Goodall G1, Lamotte M2, Ramos M2, Maunoury F3, Pejchalova B1, de Pouvourville G4 | ||||
1 Edwards Lifesciences S.A., Nyon, Switzerland 2 IQVIA, Zaventem, Belgium 3 Statesia, Le Mans, France 4 ESSEC Business School, Cergy Pontoise, France | ||||
J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30547704 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2019 | English | , Cost effectiveness | |
Health economic value of blood in Ivory coast: The case of maternal bleeding | ||||
Sekongo YM1, Asamoah-Akuoko L2, Owusu-Ofori SPO3, Lamotte M4, Bah A5, Dierick K5 | ||||
1 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan,Yvory Coast 2 National Blood Service, Accra, Ghana 3 Komfo Anokye Teaching Hospital, Kumasi, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
, Ivory Coast | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.1429 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Literature Review | |
Health economic vale of blood in Ghana: The case of maternal bleeding | ||||
Owusu-Ofori SPO1, Asamoah-Akuoko L2, Lamotte M3, Bah A4, Dierick K4 | ||||
1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 National Blood Service, Accra, Ghana 3 IQVIA, Zaventem, Belgium 4 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.1964 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea | ||||
Lee TS1, Kothari-Talwar S2, Singhal PK2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland SM6, Ju W7 | ||||
1 Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, South Korea 2 Merck and Co Inc, Kenilworth, NJ, US 3 Cubist Pharmaceuticals Inc, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, US 6 Microbiology and Infectious Diseases Department, The Royal Women's Hospital, Parkville, Victoria, Australia 7 School of Medicine, Ewha Womans University, Seoul, South Korea | ||||
BMJ Open. 2019 Mar 20;9(3):e025035 |
||||
, Article | ||||
, South Korea | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30898815 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2019 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care | |
Health economic value of blood in Sub-Saharan: The case of maternal bleeding | ||||
Owusu-Ofori SPO1, Sekongo YM2, Rajab JA3, Asamoah-Akuoko L4, Magutu V5, Lamotte M6, Bah A7, Dierick K7 | ||||
1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan, Yvory Coast 3 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Kenya 4 National Blood Service, Accra, Ghana 5 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 6 IQVIA, Zaventem, Belgium 7 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.2059 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5 | ||||
1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium | ||||
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. |
||||
, Article | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2019 | English | , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study | |
The value of blood in sub-Saharan Africa | ||||
Magutu V1, Rajab A2, Asamoah-Akuoko L3, Lamotte M4, Bah A5, Dierick K5 | ||||
1 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 2 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya 3 National Blood Service, Accra, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.2084 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis | ||||
Lau E1, Salem A2, Chan JCN1, So WY1, Kong A1, Lamotte M2, Luk A1 | ||||
1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, SAR China 2 IQVIA, Zaventem, Belgium | ||||
Cost Eff Resour Alloc. 2019 Jul 2;17:13. |
||||
, Article | ||||
, Hong Kong | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31303866 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness | |
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study | ||||
Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D’Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5 | ||||
1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy | ||||
IMW, Boston, US, 12-15 September 2019 |
||||
, Poster | ||||
, Canada, Italy, UK | ||||
Abstract: https://doi.org/10.1016/j.clml.2019.09.456 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Hematology | 2019 | English | , Epidemiological study, Observational study | |
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY | ||||
Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US | ||||
EUROGIN, Monaco, France, 4-7 December 2019 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Spain, UK, USA | ||||
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Infectious disease, Methodology | 2019 | English | , Epidemiological study, Observational study, Population Based Study | |
The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis | ||||
Freedman MS1, Duquette P2, Grand'Maison F3, Lee L4, Vorobeychik G5, Lara N6, Khurana V7, Nakhaipour HR8, Schecter R8, Haddad P8 | ||||
1 University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec , Canada 3 Neuro-Rive Sud Clinic , Greenfield Park , Quebec , Canada 4 Sunnybrook Health Sciences Centre , University of Toronto , Toronto , Ontario , Canada 5 Fraser Health Multiple Sclerosis Clinic Burnaby Hospital , Burnaby , British Columbia , Canada 6 IQVIA , Barcelona , Spain 7 Novartis Healthcare Private Limited , Hyderabad , India 8 Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada | ||||
Curr Med Res Opin. 2019 May;35(5):767-776 |
||||
, Article | ||||
, Canada | ||||
Abstract: doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21. | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Burden of illness, Retrospective Field Study | |
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood | ||||
Kent S1, Becker F1, Feenstra T2,3, Tran-Duy A4, Schlackow I1, Tew M4, Zhang P5, Ye W6, Lizheng S7, Herman W6, McEwan P8, Schramm W9, Gray A1, Leal J1, Lamotte M10, Willis M11, Palmer AJ4,12, Clarke P13,14 | ||||
1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 2 National Institute for Public Health and the Environment (RIVM), Centre for Nutrition, Prevention and Health Services Research, Bilthoven, The Netherlands 3 University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Groningen, The Netherlands 4 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia 5 Division of Diabetes Translation, Centres for Disease Control and Prevention, Atlanta, US 6 School of Public Health, University of Michigan, Ann Arbor, US 7 Department of Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, US 8 Centre for Health Economics, Swansea University, Swansea, UK 9 GECKO Institute, Heilbronn University, Heilbronn, Germany 10 IQVIA, Zaventem, Belgium 11 The Swedish Institute for Health Economics, Lund, Sweden 12 Menzies Institute for Medical Research, The University of Tasmania, Hobart, Australia 13 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 14 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia | ||||
Pharmacoeconomics. 2019 Nov;37(11):1305-1312. |
||||
, Article | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31347104 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Retrospective database analysis | |
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC) | ||||
Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6 | ||||
1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy | ||||
BMC Gastroenterology volume 20, Article number: 133 (2020) |
||||
, Poster | ||||
, Australia, Canada, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective cohort analysis | |
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach | ||||
Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5 | ||||
1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China | ||||
Value Health Reg Issues. 2019 May;18:36-46. |
||||
, Article | ||||
, China | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30419449 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness | |
The cost-effectiveness of physical activity in the management of COPD patients in the UK | ||||
Ramos M1, Lamotte M1, Gerlier L1, Svangren P2, Miquel-Cases A3, Haughney J4 | ||||
1 IQVIA, Zaventem, Belgium 2 Core Respiratory, Global Product and Portfolio Strategy - Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Mölndal, Sweden 3 Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge, UK 4 Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. | ||||
Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239 |
||||
, Article | ||||
, Scotland | ||||
Abstract: doi: 10.2147/COPD.S181194. eCollection 2019 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Respiratory disease | 2019 | English | , Cost effectiveness | |
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease | ||||
Ramos M1, Foos V1, Ustyugova A2, Hau N3, Gandhi P4, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International GmbH, Ingelheim, Germany 3 Boehringer Ingelheim Ltd, Bracknell, UK 4 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, US | ||||
Diabetes Ther. 2019 Dec;10(6):2153-2167 |
||||
, Article | ||||
, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31602601 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness | |
Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study | ||||
Buenconsejo L1, Kothari-Talwar S2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland S6 | ||||
1 Makati Medical Center, Makati, Philippines 2 Merck & Co. Inc., Kenilworth, NJ, US 3 Cubist Pharmaceuticals, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Center for Infection Research in Cancer (CIRC) at Moffitt Cancer Center, Tampa, FL US 6 Royal Women's Hospital, Melbourne, Australia | ||||
Infect Agent Cancer. 2019 Oct 7;14:26. |
||||
, Article | ||||
, Philippines | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31624494 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2019 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Observational study | |
Advancing glycemic management in people with diabetes | ||||
Aitken M1, Villa P1, Lamotte M1, Tewary V1, Ramos M1 | ||||
1 IQVIA, Zaventem, Belgium | ||||
with paper on the IQVIA institute web page |
||||
, Article | ||||
Abstract: https://www.iqvia.com/insights/the-iqvia-institute/reports/advancing-glycemic-management-in-people-with-diabetes | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2019 | English | , Cost effectiveness | |
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES | ||||
Svanström, Henrik [ 1 ]; Trojcakova, Iveta [ 1 ]; Pitcher, Ashley [ 1 ] | ||||
IQVIA, Copenhagen, Denmark | ||||
, Abstract | ||||
, Nordic | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2019 | English | , Database Study, Epidemiological study, Longitudinal study, Observational study, Survey research | |
Clinical Characteristics, Treatment Patterns, and Thromboembolic Risk of Patients With Cold Agglutinin Disease (CAD) in Japan | ||||
Toyomi Kamesaki 1, Jun-ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 | ||||
1. Jichi Medical University; 2. Osaka University, Osaka, Japan; 3. Kawasaki Medical School, Kurashiki, Japan; 4. IQVIA, Tokyo, Japan; 5. Sanofi, Waltham, MA, USA | ||||
Abstract: https://library.ehaweb.org/eha/2019/24th/266231/jun-ichi.nishimura.clinical.characteristics.treatment.patterns.and.html | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento | ||||
Juan D. Cañete1, Antonio Naranjo2, Javier Calvo3, Carmen Ordás4, Belén Aragón5, Gonzalo Nocea5, Montse Roset6, Antonio Fernández-Nebro7 | ||||
1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, España 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, España 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, España 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, España 6 Departamento de Health Economics and Outcomes Research, IQVIA, Barcelona, España 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España | ||||
Reumatología Clínica, 2019. DOI: 10.1016 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://reumatologiaclinica.org/es-patrones-tratamiento-biologico-pacientes-con-avance-S1699258X18302596 | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2019 | Spanish | , Clinical setting: hospital, Observational study | |
Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden | ||||
Lindmark K, Boman K, Olofsson M, Törnblom M, Levine A, Castelo-Branco A, Schlienger R, Wirta SB, Stålhammar J, Wikström G | ||||
Real-World & Analytics Solutions, IQVIA, Solna, Sweden | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.dovepress.com/articles.php?article_id=44704 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Verihiutaleiden estäjähoito toteutuu vajavaisesti sepelvaltimotautikohtauksen jälkeen | ||||
Eeva Reissell, Ville Kytö, Juha Halme, Tuire Prami, Sonja Lumme, Juhani Airaksinen | ||||
Eeva Reissell: National Institute for Health and Welfare | ||||
Lääkärilehti.2019; 43: 2449-54. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/verihiutaleiden-estajahoito-toteutuu-vajavaisesti-sepelvaltimotautikohtauksen-jalkeen/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | Finnish | , Population Based Study, Retrospective database analysis | |
Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland | ||||
Ville Kytö, Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen | ||||
Ville Kytö: Turku University Hospital and University of Turku | ||||
BMC Cardiovascular Disorders (2019) 19:123 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1101-8 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Population Based Study, Retrospective database analysis | |
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES | ||||
H.SvanströmI.TrojčákováA.Pitcher | ||||
IQVIA, Copenhagen, Denmark | ||||
Journal: VALUE IN HEALTH Volume: 22 Pages: S768-S768 Supplement: 3 |
||||
, Abstract | ||||
, Nordic | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2019 | English | , Population Based Study | |
Cost-offsets in relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice | ||||
Ripellino C, Pegoraro V, Heiman F | ||||
Ripellino C: HEOR Consultant Freelance, Milan, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy | ||||
CLINICO ECONOMICS ITALIAN ARTICLES ON OUTCOMES RESEARCH / VOL 14 / YEAR 2019 / PAG. 55-64 |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.clinicoeconomics.eu/articles/flipbook/14_2019_55-64/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2019 | Italian | , Cost analysis | |
Impact of Stable Angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey | ||||
Manolis AJ, Ambrosio G, Collins P, Dechend F, Lopez-Sendon J, Pegoraro V, Camm AJ | ||||
Manolis AJ: Department of Cardiology, Asklepeion General Hospital, Athens, Greece. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. | ||||
Eur J Intern Med. 2019 Dec;70:60-67. doi: 10.1016/j.ejim.2019.09.013 |
||||
, Article | ||||
, Germany, Italy, Spain, UK | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0953620519303267?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Quality of life, Survey research | |
Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study | ||||
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS. | ||||
EPID Research Oy, Espoo, Finland | ||||
BMJ |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402043/ | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Menopause |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29994974 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Int Urogynecol J |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29946829 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
Registries for Evaluating Patient Outcomes: A User’s Guide (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. 1st edition, April 2007; 2nd Edition, September, 2010; Third edition, 2014. also available in Korean (Korean National Evidence-based Healthcare Collaborating Agency, published December 2010), and in Chinese (University of Peking, published December 2012). 4th edition, in press, 2019. | ||||
Gliklich R, Dreyer N, Leavy M, eds. | ||||
, Book | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
Lessons on Data Collection and Curation from the NFL Injury Surveillance Program. Sports Health, in press. | ||||
Dreyer NA. Mack CD, Anderson RB, Wojtys EM, Hershman EB, Sills A | ||||
Sports Health 2019; 11(5): 440-445. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database. Journal of Athletic Training, in press. | ||||
Mack C, Meisel P, Herzog M, Oakkar E, Walden T, Callahan L, Shapre J, Dreyer N, DiFiori J. | ||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018 | ||||
Natlia Pascual-Argent (1,2); Carlos Crespo (1,3); Laura Planellas (4); Mriam Solozabal (4), Nria Perulero (4); Jaume Puig-Junoy (1,2) | ||||
(1) UPF Barcelona School of Management; (2) Dept. Economa y Empresa CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain | ||||
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease | 2019 | Spanish | , Clinical setting: hospital, Cost effectiveness | |
USO DE DATOS DE PRACTICA REAL PARA ANALIZAR LOS TRATAMIENTOS PRESCRITOS EN LA DIABETES TIPO 2 EN ESPA?A | ||||
Maria Targhetta*, Jean Paul Tang*, Hector Gutierrez*, Nuria Perulero*, Daniel Callejo*, Miriam Solozabal* | ||||
IQVIA Spain | ||||
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019 |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | Spanish | , Clinical setting: Primary care, Population Based Study, Retrospective database analysis | |
Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals | ||||
Zylbersztejn A, Standing J, De Stavola B, Hardelid P | ||||
IQVIA | ||||
, Abstract, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | ||
Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals | ||||
Zylbersztejn A, Standing J, De Stavola B, Hardelid P | ||||
, Oral communication | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | ||
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data. | ||||
Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K | ||||
IQVIA, Eli Lilly | ||||
Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088. |
||||
, Article | ||||
, Belgium, Canada, France, Germany, Italy, Netherlands | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Retrospective database analysis | |
ONE-YEAR ECONOMIC BURDEN AMONG PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) INITIALLY MANAGED IN THE OUTPATIENT SETTING- A RETROSPECTIVE US COHORT STUDY, 2012-2017 | ||||
Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M | ||||
IQVIA, Nabriva | ||||
Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019 |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation-paper/intl2019-2608/9913/one-year-economic-burden-among-patients-with-community-acquired-pneumonia-cap-initially-managed-in-the-outpatient-setting-a-retrospective-us-cohort-study-2012-2017 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | , Burden of illness, Retrospective database analysis | |
ECONOMIC OUTCOMES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) HOSPITALIZATIONS IN THE US- A RETROSPECTIVE COHORT STUDY, 2012-2017 | ||||
Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M | ||||
IQVIA, Nabriva | ||||
Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019 |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2019-1479/89813 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | , Burden of illness, Retrospective database analysis | |
Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis | ||||
Camper S, Divino V, Hurley D, DeKoven M | ||||
Endo; IQVIA | ||||
Journal of Hand Surgery Global Online. 2019; 1(2):57-64. |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1016/j.jhsg.2018.12.005 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Cost analysis, Retrospective database analysis | |
Return to Function in Adults with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum Versus Fasciectomy | ||||
Divino V, DeKoven M, Hurley D | ||||
IQVIA; Endo | ||||
Conference. 74TH ANNUAL MEETING OF THE ASSH. Las Vegas, Nevada, USA, 5-7 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Retrospective database analysis | |
REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe | ||||
Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U | ||||
Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC | ||||
Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3 |
||||
, Article | ||||
, Belgium, France, Germany, Spain, UK | ||||
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study | 2019 | English | , Population Based Study, Retrospective database analysis | |
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review. | ||||
Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2 | ||||
1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA | ||||
Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224 |
||||
, Article | ||||
, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
European Multi-Country Drug Utilization Study of Dulaglutide | ||||
Ayad K. Ali1, Karen E. Wells2, Mathieu Ros3, Massoud Toussi3 | ||||
1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France | ||||
ICPE, Philadelphia, USA, 24-28 August 2019 |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns | ||||
Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB | ||||
IQVIA, Cambridge, MA | ||||
Pharmacoepidemiology & Drug Safety (in press) |
||||
, Article, In press/to be published | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug Utlization Study | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Multiple imputation for systematically missing confounders within a distributed data drug safety network: a simulation study and real-world example | ||||
Secrest MH, Platt RW, Reynier P, Dormuth CR, Benedetti A, and Filion KB | ||||
IQVIA, Cambridge, MA | ||||
Pharmacoepidemiology & Drug Safety (In press) |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Methods, Results, and Lessons Learned from Two Postmarketing Drug Safety Surveillance Studies Linking State Cancer Registry Data to Large Pharmacy Databases | ||||
Harris D1; Casso D2; Midkiff K1; Anderson A2; Gilsenan A1; Oliveria SA2; Andrews E1; KellierSteele N3 | ||||
1RTI Health Solutions, Research Triangle Park, NC, United States 2IQVIA, Plymouth Meeting, PA, United States 3Eli Lilly and Company, Indianapolis, IN, United States | ||||
NAACCR / IACR Combined Annual Conference, Vancouver, Canada, 9-13 June 2019 |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.naaccr.org/wp-content/uploads/2019/06/NAACCR_IACR_Abstract_Program_Final_.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Osteosarcoma Surveillance Program Estimating the Incidence of Osteosarcoma Among Teriparatide (Forteo) Users by Linking State Cancer Registry Data to Pharmacy Database Data (United States) | ||||
Kellier-Steele N1, Anderson A2, Casso D2, Oliveria SA2, Gilsenan A3, Midkiff K3, Harris D3, Andrews E3 | ||||
1Eli Lilly and Company, Indianapolis, USA, 2IQVIA, Durham, USA, 3RTI-HS, Raleigh, USA | ||||
WCO, Paris France, 4-7 April 2019 |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.wco-iof-esceo.org/sites/wco19/pdf/WCO19-AbstractBook.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Use of maximum medical therapy in primary open-angle glaucoma: a retrospective, electronic medical records-based study from the UK | ||||
Costa VP1, Durus A2, Gondos A3, Bezlyak V2, Wintermantel T3, Sagkriotis A2, Hubatsch D4, Kim YS2 | ||||
1: Department of Ophthalmology, University of Campinas, Sao Paulo, Brazil; 2: Novartis Pharma AG, Basel, Switzerland; 3: Real World Insights, IQVIA, Basel, Switzerland; 4: Novartis Pharmaceutical Corporation Inc, Fort Worth, TX, USA | ||||
Wolrd Glaucoma Congress, Melbourne, Australia, 27-30 March 2019 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
A REVIEW OF SWEDISH HEALTH TECHNOLOGY ASSESSMENTS BASED ON INDIRECT COMPARISONS OF HOSPITAL DRUGS IN ONCOLOGY | ||||
Rongrong Zhang, Heller Vincent, Maximilian Schlueter, Ashley Pitcher | ||||
IQVIA | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: Home care, Review | |
Association between changes in anatomical and functional outcomes and physicians decisions to treat patients with licensed anti-VEGFs for neovascular age-related macular degeneration in the UK | ||||
Chakravarthy U1, Kap E2, Pillai N2, Syntosi A3, Sagkriotis A3 | ||||
1. Centre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK; 2. IQVIA, Switzerland, Germany; 3. Novartis Pharma AG, Basel, Switzerland | ||||
19th EURETINA Congress, Paris, France, 5-8 September 2019 |
||||
, Oral presentation | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Drug utilization and associated visual acuity in patients treated with anti-VEGFs for neovascular age-related macular degeneration (nAMD) in the UK | ||||
Sagkriotis A1, Bennett N2, Skelly A1, Venkatesan S3, Oyetunde S2 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom; 3. IQVIA Real World Insights, UK | ||||
19th EURETINA Congress, Paris, France, 5-8 September 2019 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Long term treatment patterns and visual outcomes of anti-vascular endothelial growth factor agents among people with neovascular age-related macular degeneration in the US | ||||
Skelly A1, Khanani AM2, Griner R3, Bezlyak V1, Clark J4, Sagkriotis A1 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. Sierra Eye Associates, Reno, Nevada, USA; 3. IQVIA, Cambridge, MA, US; 4. Novartis Pharmaceuticals, East Hanover, NJ, US | ||||
ARVO, Vancouver, Canada, April 28 - May 2 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Clinical effectiveness of switching between ranibizumab and aflibercept in treatment of neovascular AMD: US real-world outcomes | ||||
Dugel PU1, Griner R2, Ferreira A3, Milnes F3, Lotery AJ4 | ||||
1. Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, USA; 2. IQVIA Real World Solutions, USA; 3. Novartis Pharma AG, Basel, Switzerland; 4. Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK | ||||
J Vitreoretin Dis. 2019 3(3):127-134 |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1177%2F2474126419836614 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Treat and extend treatment interval patterns with anti-VEGF therapy in nAMD patients | ||||
Skelly A1, Bezlyak V1, Liew G2, Kap E3, Sagkriotis A1 | ||||
1. Novartis Pharma AG, 4002 Basel, Switzerland; 2. Westmead Institute for Medical Research, University of Sydney, Westmead NSW 2145, Australia; 3. IQVIA Commercial GmbH & Co. OHG, 60549 Frankfurt, Germany | ||||
, Article | ||||
, Australia | ||||
Abstract: https://doi.org/10.3390/vision3030041 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study | ||||
Shin SJ, You SC, Park YR, Roh J, Kim JH, Haam S, Reich CG, Blacketer C, Son DS, Oh S, Park RW | ||||
J Med Internet Res. 2019 Mar 26;21(3):e13249. doi: 10.2196/13249 |
||||
, Article | ||||
Abstract: https://www.jmir.org/2019/3/e13249/ | ||||
Condition | Year | Language | Analysis type | |
2019 | English | , Methodology | ||
Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care | ||||
Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y | ||||
Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019 |
||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30906191 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Methodology | |
Expanding the role of PETs in the data protection and privacy narrative | ||||
39. K. El Emam | ||||
IQVIA | ||||
Journal of Data Protection and Privacy, 2(3):198-200, 2019. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
2019 | English | , De-identification / anonymisation | ||
Comparing the benefits of pseudonymisation and anonymisation under the GDPR | ||||
M. Hintze and K. El Emam | ||||
Journal of Data Protection and Privacy, 2(2):145-158, 2018. |
||||
Condition | Year | Language | Analysis type | |
2019 | English | , De-identification / anonymisation | ||
Understanding post discharge management after an acute myocardial infarction in Italy: regional pathways and outcome index | ||||
Mastrorilli G1, Tettamanti A1, Urbinati D1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | ||
Real-world evidence on patients with relapse/refractory FLT3 mutation-positive acute myeloid leukemia in Italy | ||||
La Malfa P1, Arenga A1, De Santo E1, Urbinati D1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Real World Data, Real World Evidence | |
The impact of out-of-pocket spending on the preparation of generic drugs after the expiry of the market exclusivity | ||||
Cioni L1, Tettamanti A1, Urbinati D1 | ||||
IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Market impact, Public Health | |
Assessment of the oncological offer among Italian regions: a patient-centered analysis | ||||
Rova A1, Tettamanti A1, Pinto L1, Urbinati D1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Public Health | |
European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life | ||||
Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7 | ||||
1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. Georges University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charit Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Survey research | |
Change in treatment paradigm of ALK+ Non-Small Cell Lung Cancer (NSCLC) in the Italian real practice | ||||
Tucci C1, Urbinati D1, De Santo E1, Fico M2, Fioravanti L2, Demma F2 | ||||
1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Public Health, Real World Data, Real World Evidence | |
Brentuximab Vedotin for consolidation therapy after ASCT in CD30+ Hodgkin's limphoma: a sustainable pharmaceutical expenditure for the Italian National Health Service | ||||
Peduto I1, Heiman F1, Morelli P2, Fioravanti L2, Demma F2 | ||||
1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Cost analysis, Economic evaluation | |
Patients prescribed with opioid treatment in primary care practices: a population-based study in Italy | ||||
Peduto I1, Pegoraro V1, Cipelli R1, Heiman F1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2019 | English | , Database Study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective database analysis | |
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries | ||||
Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2 | ||||
1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy | ||||
Annals of Hematology (2019) 98:15731582 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy | ||||
Carnio S1, Galetta D2, Pilotto S3, Scotti V4, Cortionovis DL5, Antonuzzo A6, Pisconti S7, Rossi A8, Martelli O9, Cecere FL10, Lunghi A11, Del Conte A12, Montrone M2, Topulli J4, Canova S5, Rapetti SG1, Gianetta M1, Pacchiana MV1, Capelletto E1, Pegoraro V13, Cataldo N13, Bria E3 and Novello S1 | ||||
1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy 2 Clinical Cancer Center Giovanni Paolo II, Bari, Italy 3 U.O.C. Oncology, Department of Medicine, University of Verona, Italy 4 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 5 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 6 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 7 Department of Onco-Ematology Medical Oncology, SG Moscati Hospital, Taranto, Italy 8 Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 9 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 10 Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy 11 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 12 IRCCS - Oncological Reference Center (CRO) - U.O. Oncology, Pordenone-S. Vito, Italy 13 IQVIA, Milan, Italy | ||||
J Cancer Sci Ther 2018, 10:9 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Survey research | |
Real-world insights on the management of migraine patients: an Italian nationwide study | ||||
Agostoni E1, Barbanti P2, Frediani F3, Trifir G4, Burgio L5, di Nola L5, Pegoraro V6, Pulimeno S5, Cepparulo M5 | ||||
1 Neurology and Stroke Unit, Department of Neurosciences, Niguarda Neuro Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy 2 Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, IRCCS San Raffaele Pisana, Rome, Italy - San Raffaele University, Rome, Italy 3 Headache Center, Neurology and Stroke Unit Division, S. Carlo Borromeo Hospital, ASST Santi Paolo e Carlo, Milan, Italy 4 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy 5 TEVA Italia Srl, Milan, Italy 6 IQVIA, Milan, Italy | ||||
Curr Med Res Opin. 2019 Mar 29:1-10 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Pain | 2019 | English | , Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database | ||||
Marzioni M1, Bassanelli C2, Ripellino C3, Urbinati D3, Alvaro D4 | ||||
1 Clinic of Gastroenterology and Hepatology, Universit Politecnica delle Marche, Ancona, Italy 2 Intercept Italia srl, Milan, Italy 3 IQVIA, Milan, Italy 4 Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy | ||||
Dig Liver Dis. 2019 May;51(5):724-729 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2019 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
The Pharmacoepidemiology of Anti-Depressant Prescribing Trends in Canadian Children from 2012 to 2016 | ||||
Aysha Lukmanji1BA&Sc, Tamara Pringsheim2,3MD, Andrew G. Bulloch1,3PhD, David G Stewart1, Parco Chan1, Ali Tehrani1, Scott B. Patten1,3,4MD PhD | ||||
1Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW Calgary, Alberta T2N 4Z6, Canada 2 Department of Clinical Neurosciences 3 Mathison Center for Research & Education, Hotchkiss Brain Institute, University of Calgary 4Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary. 5 IQVIA Canada | ||||
J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018 |
||||
, Article | ||||
, Canada | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31355670 | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
PRODUCTIVITY LOSS IN THE FIRST YEAR AFTER A CARDIOVASCULAR EVENT IN CANADA: A CROSS SECTIONAL STUDY OF WORKING ADULTS | ||||
A. Shekhar Pandey, B.Sc., MD, FRCPC, ABIM, CBNC;1 Milan Gupta, MD, FRCPC, FACC;1 Theodore Wein, MD, FRCPC, FAHA;2 Aren Fischer, MSc;3 Johanna Mancini, BSc, MSc, PhD;3 Eduard Sidelnikov, MD, PhD;4 Raina Rogoza, MSc;5 Louisa Pericleous, MSc, PhD.5 | ||||
1Department of Medicine, McMaster University, Hamilton, ON, Canada; 2Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; 3IQVIA, Mississauga, ON, Canada; 4AMGEN, Europe GmbH, Rotkreuz, Switzerland; 5AMGEN; Mississauga, ON, Canada. | ||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | ||
Trends in Psychotropic Medication Use for Canadian Children and Youth with ASD from 2010 to 2016: A Pharmacoepidemiologic Study | ||||
McMorris, C.A.1, Patten, S.2, Stewart, D.3, Tehrani, A.3 & Pringsheim, T.2 | ||||
1 Werklund School of Education, University of Calgary (Calgary, AB Canada) 2 Cumming School of Medicine, University of Calgary (Calgary, AB Canada) | ||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2019 | English | , Database Study | |
Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study | ||||
Nicholas Cothros1, Davide Martino1, Carly McMorris2,3, David Stewart4, Ali Tehrani4 & Tamara Pringsheim1,5,6* | ||||
1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Foothills Hospital, Calgary, AB, CA, 2Werklund School of Education, Alberta Childrens Hospital Research Institute (ACHRI), University of Calgary, Calgary, AB, CA, 3The Owerko Centre, Child Development Centre (CDC), Calgary, AB, CA, 4IQVIA, Kanata, ON, CA, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, AB, CA, 6Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, CA | ||||
Tremor Other Hyperkinet Mov (N Y)v.9; 2019 |
||||
, Article | ||||
, Canada | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691607/ | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2019 | English | , Survey research | |
LANDSCAPE TRANSFORMATION: pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY | ||||
Minhas, Jagdeep, M.Biotech1; Iqbal-Khan, Sarah, MBA2; Laforty, Callahan, MSc2; Ling, Juejing, MSc2; Shi, Scott, PharmD2; Millson, Brad, MBS1 | ||||
1Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8; 2Health Access and Outcomes, IQVIA, 6700 Century Avenue, Mississauga, ON, L5N 6A4 | ||||
CADTH Symposium 2019, Edmonton, AB, April 14-16, 2019 |
||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
Anti-VEGF persistence and switching in nAMD: real world analysis from a Canadian claims database | ||||
Tina Maio-Twofoot 1, Alexandros Sagkriotis 2, Atif Kukaswadia 3, Franois Lebeau 1, Valerie Gregory 1 | ||||
1 Novartis Pharmaceuticals Canada Inc., 2 Novartis Pharma AG; 3 IQVIA | ||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , Longitudinal study, Observational study, Retrospective database analysis | |
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada | ||||
Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1 | ||||
1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada. | ||||
Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7. |
||||
, Article | ||||
, Canada, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937 | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2019 | English | ||
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis | ||||
Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4 | ||||
1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA | ||||
Annals of the Rheumatic Diseases 2018;77:494. |
||||
, Article | ||||
, Canada | ||||
Abstract: https://acrabstracts.org/abstract/reduction-in-the-utilization-of-prednisone-and-or-methotrexate-following-the-initiation-of-etanercept-in-pediatric-patients/ | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics, Rheumatology | 2019 | English | , Longitudinal study, Retrospective database analysis | |
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study | ||||
Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale | ||||
Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019 |
||||
, Article | ||||
, Canada | ||||
Abstract: ?https://doi.org/10.1080/03007995.2019.1636543 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | English | , Retrospective cohort analysis | |
Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden. | ||||
Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T | ||||
Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde) | ||||
Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis | |
Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study. | ||||
Larsson K1, Janson C2, Stllberg B3, Lisspers K3, Olsson P4, Kostikas K5, Gruenberger JB5, Gutzwiller FS5, Uhde M6, Jorgensen L7, Johansson G3. | ||||
Work Environment Toxicology, Karolinska Institutet, Stockholm, Sweden (Larsson) and IQVIA Sweden (Uhde) | ||||
Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:995-1008. doi: 10.2147/COPD.S195382. eCollection 2019. |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31190785 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | , Clinical setting: Primary care, Epidemiological study, Retrospective cohort analysis | |
Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study | ||||
Blankenburg M1, Fett AK2, Eisenring S3, Haas G2, Gay A4 | ||||
1. Bayer AG, Market Access, Berlin, Germany; 2. IQVIA Commercial GmbH & Co OHG, Frankfurt/Main, Germany; 3. IQVIA, Basel, Switzerland; 4. Bayer AG, Medical Affairs, Berlin, Germany | ||||
BMC Nephrology 2019;20:171 |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1186/s12882-019-1348-4 | ||||
Condition | Year | Language | Analysis type | |
, Nephrology | 2019 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
CLUE: Consequences for life of children with in utero exposure to metformin in Finland | ||||
Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
The International Diabetes Federation (IDF) Congress 2019 |
||||
, Oral presentation | ||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis | |
An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer. | ||||
Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J. | ||||
JCO Clinical Care Informatics 2019. 3:1-15. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | ||
Adoption of immuno-oncology in NSCLC, a real-world study in EU5. | ||||
Alejandra Martinez De Pinillos,Isabel Ricote Lobera,Cristina Martinez,Caroline Anger,Filippo Guglielmetti,Roberto Jorge Bitton | ||||
IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina | ||||
Journal of Clinical Oncology201937:15_suppl,e20631-e20631 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective database analysis | |
EPIDEMIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDERS IN SPAIN BASED ON REAL-WORLD DATA | ||||
Ramos-Quiroga JA (1), Targhetta M (2), Gasche D (2), Rubio M (2), Perulero N (3) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain; 3IQVIA Information, Barcelona, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Análisis de la implementación de los Informes de Posicionamiento Terapéutico en España | ||||
Míriam Solozabal, Laura Planellas, Elisabet Viayna, Neus Canal | ||||
Health Economics & Outcomes Research. Real-World Insights. IQVIA España | ||||
Revista Española de Economía de la Salud. 2019; 14(3):596-605 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.economiadelasalud.com/Articulo.aspx?i=v14n3d018 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement, Public Health | 2019 | Spanish | , Clinical setting: hospital, Clinical setting: Primary care, Internet or Interactive voice response system, Pricing & Reimbursement, Public Health | |
A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN | ||||
Ramos-Quiroga JA (1), Tang JP (2), Solozabal M (2), De Prado A (2), Miñarro C (2), Callejo-Velasco D (2) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
EMPAGLIFLOZIN VS SITAGLITPIN, SAXAGLIPTIN AND LIRAGLUTIDE IN SPAIN. A BUDGET IMPACT MODEL BASED ON THE CORE DIABETES MODEL AND CARDIOVASCULAR OUTCOMES TRIALS | ||||
Carrasco Perez M, Ustyugova A, Rubio M, Callejo-Velasco D, Gasche D, Gonzalez-Rojas Guix N | ||||
Boehringer Ingelheim and IQVIA | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Budget impact, Clinical setting: Primary care | |
Ankle Sprains in the National Basketball Association, 2013-14 through 2016-17. | ||||
Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW | ||||
American Journal of Sports Medicine 2019 Sep;47(11):2651-2658. doi: 10.1177/0363546519864678. Epub 2019 Aug 7 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time. | ||||
Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM | ||||
VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag. | ||||
Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273. |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis | |
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time. | ||||
Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM | ||||
VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag. | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368 | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain. | ||||
Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W. | ||||
IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK. | ||||
Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | English | , Retrospective cohort analysis | |
Comparative Efficacy and Tolerability of Lurasidone versus Other Oral Atypical Antipsychotics for the Treatment of Pediatric Schizophrenia: A Network Meta-Analysis | ||||
Arango C, Ng-Mak D, Finn E, Byrne A, Rajagopalan K, Loebel A | ||||
Chair Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, IBERSAM, Madrid, Spain Senior Director, Global Health Economics & Outcomes Research, Sunovion Pharmaceuticals Inc, Marlborough, MA, USA QuintilesIMS, London, United Kingdom Head of Global HEOR, Global Health Economics and Outcomes Research, Sunovion Pharmaceuticals, Marlborough, MA Executive Vice President, Chief Medical Officer, Research & Development, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA | ||||
30th Annual U.S. Psych Congress; 2017 Sept 15-19; New Orleans (USA) European Psychiatric Association; 2018 Mar 3-6; Nice, France. NEI Congress Scientific Poster Session; 2017 Nov 10; Colorado Springs (USA). Lurasidone in Bipolar Depression: Update of SLR and NMA |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.psychcongress.com/posters/comparative-efficacy-and-tolerability-lurasidone-versus-other-oral-atypical-antipsychotics | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Pediatrics | 2019 | English | , Meta analysis, Retrospective cohort analysis | |
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE | ||||
Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi | ||||
Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands | ||||
Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019 |
||||
, Poster | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Musculoskeletal disease | 2019 | English | , Survey research | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
Every Mother Counts: Target Sample Size Estimates for Pregnancy Exposure Registries | ||||
Bratton EW, Lee KM, Hawkes WG, Landi SN, Hahn KA | ||||
IQVIA Durham, NC; NoviSci, Durham, NC | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2019 | English | , Population Based Study, Real World Data | |
Outcome measurement in pregnancy exposure registries: A preliminary review of publicly available resources | ||||
Suzanne N. Landi, Jessica R. Probst , Katherine Lee, , Elsa García Hernández , Kristen Hahn | ||||
IQVIA, Durham, NC NoviSci Inc., Durham, NC | ||||
, Europe, USA | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2019 | English | , Population Based Study, Review | |
The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan ? a retrospective database study | ||||
Rie Ueno, Shinichi Nishimura, Go Fujimoto, Yi Piao & Katsuto Takenaka | ||||
a MSD K.K. , Tokyo , Japan. b IQVIA Solutions Japan K.K. , Tokyo , Japan. c Department of Hematology, Clinical Immunology and Infectious Diseases, Graduate School of Medicine, Ehime University , Toon , Japan. | ||||
Curr Med Res Opin. 2019 Aug 11:1-8 |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1649379?needAccess=true& | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy- An Observational Pharmacy Claims Database Study | ||||
Tatsuya Umeda; Ai Hayashi; Go Fujimoto; Yi Piao; Nobutomo Matsui; Shigeru Tokita, | ||||
Medical Affairs, MSD K.K. Real World Insights, IQVIA Solutions Japan K.K. | ||||
Circulation Journal Circ J. 2019 Jul 25;83(8):1689-1697 |
||||
, Abstract, Article, Poster | ||||
, Japan | ||||
Abstract: https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-18-1344/_pdf | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Determining Real-World Data’s Fitness for Use and the Role of Reliability | ||||
Nirosha Mahendraratnam Christina Silcox Kerra Mercon Adam Kroetsch Morgan Romine Nicholas Harrison Adam Aten Rachel Sherman Gregory Daniel* Mark McClellan | ||||
The Robert J. Margolis, MD, Center for Health Policy at Duke University is directed by Mark McClellan, MD, PhD, and brings together expertise from the Washington, DC, policy community, Duke University, and Duke Health to address the most pressing issues in health policy. The mission of Duke-Margolis is to improve health and the value of health care through practical, innovative, and evidence-based policy solutions. Duke-Margolis catalyzes Duke University’s leading capabilities, including interdisciplinary academic research and capacity for education and engagement, to inform policy making and implementation for better health and health care. For more information, visit healthpolicy.duke.edu. | ||||
https://healthpolicy.duke.edu/sites/default/files/atoms/files/_determining_real-world_datas_fitness_for_use_and_the_role_of_reliability.pdf |
||||
, Health authorities guidelines/assessment report, Report | ||||
Abstract: https://healthpolicy.duke.edu/publications/determining-real-world-data’s-fitness-use-and-role-reliability | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Health policy | 2019 | English | , Retrospective database analysis | |
When Context Is Hard to Come By: External Comparators and How to Use Them. | ||||
Mack C, Christian J, Brinkley E, Warren EJ, Hall M, Dreyer N | ||||
IQVIA Real-World & Analytic Solutions, Durham, NC, USA. IQVIA Real-World & Analytic Solutions, Rockville, MD, USA. IQVIA Real-World & Analytic Solutions, Cambridge, MA, USA | ||||
Ther Innov Regul Sci. 2019 Nov 5:2168479019878672. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31690113 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2019 | English | , Retrospective database analysis | |
AN EARLY LOOK AT THE SECOND DOSE COMPLETION OF THE RECOMBINANT ZOSTER VACCINE (RZV) IN CANADIAN ADULTS ? A RETROSPECTIVE ANALYSIS | ||||
Ashleigh McGirr1, Tara Bourgoin2, Michael Wortzman1, Brad Millson2, Shelly McNeil3 | ||||
1GSK, Mississauga, Canada, 2IQVIA, Ot tawa, Canada, 3Canadian Center for Vaccinology, IWK Heal th Centre and Nova Scotia Health Authority, Dalhousie University | ||||
The CIRN Annual Meeting, 20 & 21 November 2019 - Toronto, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://gsk.envisionpharma.com/dv_gsk_bio/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2019 | English | , Retrospective database analysis | |
A budget impact analysis of anti-inhibitor coagulant complex use in pediatric hemophilia A patients with inhibitors across kingdom of Saudi Arabia | ||||
Al Jedai A1, AL-Mudaiheem H1, Al daamah S2, Al kasim F3, Wasri A4, Shaheen N5, Dawood E6, El-Hamaidi I7, Mohamed O8 | ||||
1Ministry of Health, Riyadh, NJ, USA, 2Ministry of Health, Damam, Saudi Arabia, 3Ministry of Health, Riyadh, Saudi Arabia, 4Ministry of National Guards, Jeddah, Saudi Arabia, 5King Faisal Specialized Hospitals, Damam, Saudi Arabia, 6Ministry of Health, Mekkah, Saudi Arabia, 7Ministry of National Guards, Riyadh, Saudi Arabia, 8IQVIA, Dubai, DU, United Arab Emirates | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Saudi Arabia | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/96011 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Rare disease | 2019 | English | , Budget impact | |
Cost of inflammatory bowel disease management in the kingdom of Saudi Arabia | ||||
Al Jedai A1, AL-Mudaiheem H1, Haines A2, Mosli M3, Albogami M4, Al-jaroudi F5, Alsaqa'aby M6, Awad N7, Mohamed O8 | ||||
1Ministry of Health, Riyadh, NJ, USA, 2Toronto University, Toronto, ON, Canada, 3King Abdulaziz University, Jeddah, Saudi Arabia, 4Ministry of Health, Damam, Saudi Arabia, 5King Fahad Specialist Hospital, Damam, Saudi Arabia, 6King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia, 7IQVIA, Dubai, United Arab Emirates, 8IQVIA, Dubai, DU, United Arab Emirates | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Saudi Arabia | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/97718 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2019 | English | , Budget impact, Literature Review | |
Extracting UMLS Concepts from Medical Text Using General and Domain-Specific Deep Learning Models | ||||
Kathleen C. Fraser1, Isar Nejadgholi1, Berry De Bruijn1, Muqun Li2, Astha LaPlante2 , Khaldoun Zine El Abidine2 | ||||
1National Research Council Canada 2Privacy Analytics Inc., Ottawa, Canada | ||||
[v1] Thu, 3 Oct 2019 01:51:17 UTC |
||||
, Article | ||||
, USA | ||||
Abstract: https://arxiv.org/abs/1910.01274 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2019 | English | , Methodology, Observational study, Public Health | |
Economic evaluation of cladribine tablets in relapsing multiple sclerosis (RMS) patients with high disease activity (HAD) in lebanon | ||||
Metni M1, Yamout B2, Koussa S3, Khamis C3, Fleifel L4, Sharifi S4, Mohamed O5 | ||||
1National Social Security Fund, Beirut, NJ, Lebanon, 2American University if Beirut, Beirut, NJ, Lebanon, 3Geitaoui hospital, Beirut, Lebanon, 4Merck Serono Middle East FZ-Ltd, an affiliate of Merck KGaA, Dubai, 07, United Arab Emirates, 5IQVIA, Dubai, NJ, United Arab Emirates | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Lebanon | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/95423 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Budget impact, Cost utility | |
The cost effectiveness of enoxaparin in the prevention of venous thromboembolism in patients undergoing major surgery in egypt | ||||
Farag A1, Abdel Moety H1, Hassan L2, Pathak P3, Lamotte M4, Levorsen A5 | ||||
1Cairo University, Cairo, Egypt, 2Alexandria University, Alexandria, Egypt, 3QuintilesIMS, Dubai, United Arab Emirates, 4IQVIA, Zaventem, VBR, Belgium, 5Sanofi, Global, France | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Egypt | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3118/94222 | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine | 2019 | English | , Cost effectiveness, Literature Review | |
THE COST OF STIGMA ASSOCIATED WITH HIV- A COST-CONSEQUENCE ANALYSIS TO EVALUATE HIV TESTING AND PREVENTION INTERVENTIONS IN KSA | ||||
Filemban S1, Elrashied S1, Assiri A1, Hakawi A1, Snehanshu S2, Mansour E3, Vemer P4, Awad N5 | ||||
1Ministry of Health, Riyadh, Saudi Arabia, 2Gilead Sciences Middle East, Dubai Health Care City, United Arab Emirates, 3Gilead, Dubai, United Arab Emirates, 4Groningen University, Groningen, Netherlands, 5IQVIA, Dubai, United Arab Emirates | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Saudi Arabia | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/97847 | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2019 | English | , Predictive analytics, Quality of life | |
An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany | ||||
Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4 & Dirk Lennartz5 | ||||
1Lilly and Company, Indianapolis, USA; 2Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany; 3Eli Lilly and Company, Surrey, United Kingdom; 4IQVIA, Real-World Evidence Solutions, Barcelona, Spain; 5IQVIA, Real-World Evidence Solutions, Munich, Germany. | ||||
Endocrine Abstracts (2019) 63 P207 | DOI: 10.1530/endoabs.63.P207 |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063P207 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Compliance, Survey research | |
Budget impact analysis of tofacitinib in adult rheumatoid arthritis patients in Iraq | ||||
N. AlAni1, N. Sunna2, A. Ghorab3, A. AlJabban4, N. Awad5, O. Mohamed5 | ||||
Baghdad College of Medicine, Baghdad, Iraq, Pfizer, Amman, Jordan, ; Pfizer, Dubai, United Arab Emirates; Pfizer, Baghdad, NJ, USA; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.705 |
||||
, Article | ||||
, Iraq | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30897-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Budget impact, Prospective study | |
Budget Impact Analysis Of Golimumab In Adult Rheumatoid Arthritis Patients In Kingdom Of Saudi Arabia | ||||
A. Al Jedai1, H. AL-Mudaiheem1, P. Pathak2, N. Awad2, O. Mohamed2, N. Alghanim1, W. Hussain1, A. Qamar1, T. Alama1 | ||||
Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.087 |
||||
, Article | ||||
, Saudi Arabia | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30279-7/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Budget impact, Predictive analytics | |
Cost of treating iron deficiency anaemia (ida) with ferric carboxymaltose versus iron saccharate in heavy uterine bleeding (hub) patients in the kingdom of Saudi Arabia | ||||
A. Alhejazi1, O. Mohamed2, M. Alhowimel1, M. Al Adham1 | ||||
Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.824 |
||||
, Article | ||||
, Saudi Arabia | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31016-2/abstract | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Womens Health | 2019 | English | , Budget impact, Predictive analytics | |
A network meta analysis comparing C1 and kallikrein inhibitors approved for prophylaxis of hereditary angioedema in the United States | ||||
P. Saharia1, P. Soni2, M. Chatterjee3 | ||||
IQVIA, Gurugram, HR, India; IQVIA, Delhi, India; IQVIA, Gurugram, India | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.1641 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31833-9/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Rare Diseases | 2019 | English | , Literature Review, Meta analysis | |
Cost effectiveness of cladribine tablets for treatment of RRMS in the Netherlands | ||||
de Francesco M1, Mahajan K2, Michels RE3, Schiffers K4, Budhia S5, Harty G6, Krol M3 | ||||
1IQVIA, Zaventem, Belgium, 2IQVIA, Gurgaon, India, 3IQVIA, Amsterdam, The Netherlands, 4Merck B.V., an affiliate of Merck KGaA, Schiphol-Rijk, The Netherlands, 5PAREXEL International, Waltham, MA, USA, 6EMD Serono, Billerica, MA, USA | ||||
2018-11, ISPOR Europe 2018, Barcelona, Spain |
||||
, Article | ||||
, Netherlands | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-europe-2018/cost-effectiveness-of-cladribine-tablets-for-treatment-of-rrms-in-the-netherlands | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Cost effectiveness, Predictive analytics | |
Mid-upper arm circumference as a substitute of the body mass index for assessment of nutritional status among adult and adolescent females: learning from an impoverished Indian state. | ||||
Das A, Sai Mala G, Reddy N, Mishra P, Giri R, Kumar A, Raj A, Kumar G, Chaturvedi S, Babu S, Srikantiah S, Mahapatra T. | ||||
Lead author: Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (At the time of publication, the author was with CARE India Solutions for Sustainable Development) | ||||
Public Health |
||||
, Article | ||||
, India | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0033350619302963 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Nutritional Disorders | 2019 | English | , Cost minimization, Epidemiological study, Observational study, Population Based Study, Public Health | |
Prelacteal feeding practice and maintenance of exclusive breast feeding in Bihar, India – identifying key demographic sections for childhood nutrition interventions: a cross-sectional study. | ||||
Das A, Sai Mala G, Singh RS, Majumdar A, Chatterjee R, Chaudhuri I | ||||
Lead author: Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (At the time of publication, the author was with CARE India Solutions for Sustainable Development) | ||||
Gates Open Research |
||||
, Article | ||||
, India | ||||
Abstract: https://gatesopenresearch.org/articles/3-1 | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2019 | English | , Observational study, Population Based Study, Public Health | |
Where there is no nurse: an observational study of large-scale mentoring of auxiliary nurses to improve quality of care during childbirth at primary health centres in India. | ||||
Rao KD, Srivastava S, Warren N, Mayra K, Gore A, Das A, Ahmed S. | ||||
Lead author: Department of International Health, Johns Hopkins University Bloomberg School of Public Health. One of the contributing author is Aritra Das who is affiliated to Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (he was formerly with CARE India Solutions for Sustainable Development) | ||||
BMJ Open |
||||
, Article | ||||
, India | ||||
Abstract: https://bmjopen.bmj.com/content/bmjopen/9/7/e027147.full.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Observational study, Public Health | |
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden | ||||
"Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group" | ||||
*Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland | ||||
AAN, Philadelphia, USA, 4-10 May 2019 |
||||
, Oral presentation | ||||
, Europe, Finland, Nordic, Sweden | ||||
Abstract: https://n.neurology.org/content/92/15_Supplement/S49.005 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study | |
No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS | ||||
R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. Sabidó 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. Mehtälä 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group | ||||
1StatFinn-EPID Research, Espoo, Finland | ||||
EAN, Oslo, Norway, June 29-2 July, 2019 |
||||
, Oral presentation | ||||
, Finland, Germany, Norway, Sweden, Switzerland, UK | ||||
Abstract: https://www.ean.org/fileadmin/_files/AbstractBook/EAN_Journal_2019_Book.pdf | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS | ||||
Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group | ||||
1StatFinn-EPID Research, Espoo, Finland | ||||
ECTRIMS, Stockholm, Sweden, 11-13 September, 2019 |
||||
, Poster | ||||
, Finland, Nordic, Sweden | ||||
Abstract: https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/278346/pasi.korhonen.prevalence.of.infant.outcomes.at.birth.after.exposure.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmontgomery | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study. | ||||
Meers S1, Bailly B2, Vande Broek I3, Malfait B4, Van Hoorenbeeck S4, Geers J4, Braakman J5, Van Kouwenhove M6, Doyle M7, Diels J8, Caekelbergh K9, Chevalier P9, Dierickx D10. | ||||
1 Department Oncology, AZ Klina , Brasschaat , Belgium. 2 Department Haematology, Groupe Jolimont , Haine Saint-Paul , Belgium. 3 Department Oncology, AZ Nikolaas , Haematology, Sint Niklaas , Belgium. 4 Department Market Access, Janssen-Cilag NV , Beerse , Belgium. 5 Department Market Access, Janssen-Cilag BV , Breda , The Netherlands. 6 Department Medical, Janssen-Cilag BV , Breda , The Netherlands. 7 Department Medical, Janssen Ireland , Dublin 24 , Ireland. 8 Department Statistics and Modelling, Janssen Pharmaceutica NV , Beerse , Belgium. 9 Department Real-World Solutions, IQVIA , Zaventem , Belgium. 10 Department Haematology, UZ Leuven , Leuven , BelgiumDepartment Haematology. | ||||
, Abstract | ||||
, Belgium | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31551014 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2019 | English | , Retrospective database analysis | |
Epidemiology of Ankle Sprains and Chronic Ankle Instability. | ||||
Herzog MM, Kerr ZY, Marshall SW, Wikstrom EA | ||||
Department of Epidemiology, University of North Carolina at Chapel Hill; Real-World Analytics Solutins, IQVIA; University of North Carolina Injury Prevention Research Center | ||||
J Athl Train. 2019 Jun;54(6):603-610. doi: 10.4085/1062-6050-447-17 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31135209 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2019 | English | , Epidemiological study | |
Ankle Sprains in the National Basketball Association, 2013-2014 Through 2016-2017 | ||||
Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW. | ||||
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; University of North Carolina Injury Prevention Research Center; Injury Surveillance and Analytics, Real-World Analytics Solutins, IQVIA | ||||
Am J Sports Med. 2019 Sep;47(11):2651-2658 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/31389712 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2019 | English | , Epidemiological study | |
The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database | ||||
Mack CD, Meisel P, Herzog MM, Callahan L, Oakkar EE, Walden T, Sharpe J, Dreyer NA, DiFiori J | ||||
IQVIA Real-World & Analytics Solutions, Research Triangle Park, Durham, NC. University of North Carolina at Chapel Hill. National Basketball Association, New York, NY. Hospital for Special Surgery, New York, NY. National Basketball Athletic Trainers Association, Charlotte, NC. | ||||
ncbi.nlm.nih.gov/pubmed/31074633 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31074633 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Injuries, Orthopedics | 2019 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden | ||||
Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong | ||||
IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden | ||||
ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34089-6/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301519340896%3Fshowall%3Dtrue#%20 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2019 | English | , Review | |
Initial Management of localised prostate cancer in the Elderly: An International Data Review | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
SIOG 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
COMPARING THE ROLE OF DIFFERENT SPECIALITIES IN THE MANAGEMENT OF PROSTATE CANCER IN FRANCE AND ITALY: INSIGHTS FROM A REAL-WORLD STUDY | ||||
Mpima S , Nasuti P , Casey V | ||||
IQVIA London , UK | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: Primary care | |
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data | ||||
Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer, Philip Levin | ||||
Huan Huang, IQVIA | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2018.1437027 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
JCO ( ASCO 2018) |
||||
, Abstract | ||||
, Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES | ||||
Takeno S1, Tanaka S1, Saijo N1 Nasuti P2 | ||||
1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK | ||||
ISPOR 2018 APAC |
||||
, Poster | ||||
, Asia Pacific, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data. | ||||
Husereau D1, Goodfield J2, Leigh R3, Borrelli R2, Cloutier M2, Gendron A4,5. | ||||
1Department of Epidemiology and Community Medicine, School of Epidemiology and Public Health, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON K1G 5Z3 Canada 2IQVIA, Mississauga, ON Canada 3Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB Canada 4AstraZeneca Canada Inc, Mississauga, ON Canada 5Department of Medicine, University of Montreal, Montreal, QC Canada | ||||
Allergy Asthma Clin Immunol. 2018 Apr 24;14:15. |
||||
, Article | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective database analysis | ||
Drug treatment in melanoma: a real-world analysis across Europe and Japan | ||||
Martinez de Pinillos, Anger C, Nasuti P | ||||
IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Treatment algorithm for multiple myeloma: real-world insights across five European countries | ||||
Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2 | ||||
1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries | ||||
Hoyer L, Schmidt N | ||||
IQVIA Frankfurt Germany | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) | ||||
Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 | ||||
IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data | ||||
Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 | ||||
1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4) | ||||
Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2 | ||||
1IQVIA Milan Italy , 2IQVIA London UK | ||||
CTOS 2018 Rome |
||||
, Poster | ||||
, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE | ||||
Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2 | ||||
1 IQVIA London UK , 2IQVIA Madrid Spain | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France | ||||
Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6 | ||||
1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health economics, Oncology | 2018 | English | , Budget impact, Literature Review, Public Health | |
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION. | ||||
Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F* | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology | 2018 | English | , Cost effectiveness, Market impact, Review | |
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE. | ||||
Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles | ||||
RWI IQVIA France | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases | 2018 | English | , Cost effectiveness, Pricing & Reimbursement, Willingness to pay | |
A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE | ||||
Petrica N (1), Beaudier E(1),Exposto F (2), Beaudet A(3) | ||||
(1) IQVIA, Paris France (2) IQVIA, London UK (3) Actelion Pharmaceuticals Ltd, Switzerland | ||||
ISPOR 2018 |
||||
, Article, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Cost analysis, Cost of illness, Retrospective database analysis | |
Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study | ||||
Janson C, Johansson G, Ställberg B, Lisspers K, Olsson P, Keininger DL, Uhde M, Gutzwiller FS, Jörgensen L and Larsson K | ||||
Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Akademiska sjukhuset, 75185 Uppsala, Sweden|IQVIA, Stockholm, Sweden|IQVIA, Copenhagen, Denmark | ||||
Respiratory Research (2018) 19:172 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0868-y | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Observational study, Population Based Study | |
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 | ||||
1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France | ||||
European Society of Cardiology (ESC) Congress, 2018, Munich, Germany |
||||
, Poster | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients | ||||
Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger J-B, Gutzwiller F, Jorgensen F, Uhde M and Lisspers K | ||||
Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden|IQVIA, Stockholm, Sweden|IQVIA, Copenhagen, Denmark | ||||
npj Primary Care Respiratory Medicine (2018) 28:33 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.nature.com/articles/s41533-018-0101-y | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Retrospective cohort analysis | |
Rare disease development programs: An update | ||||
Wu J, Want C, Horton DB, Petersen I, Oliveria S, Blackburn S, Jiang J, LoCasale R. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):5. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | ||
Identification of a hereditary angioedema cohort in a US ambulatory EMR database | ||||
Brouwer E, Bratton E, Near A, Lang K, Mack C | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2): 136-137. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | ||
Patient and caregiver indirect costs after acute cardiovascular events in Europe. | ||||
Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5 | ||||
1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium | ||||
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
, Oral presentation | ||||
, Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia | ||||
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes. | ||||
Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M | ||||
Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351. |
||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2018 | English | ||
Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes. | ||||
Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M | ||||
Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351. |
||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | ||
ECONOMIC IMPACT OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE | ||||
Vasilescu L , Champs F-O1, Durand-Zaleski I | ||||
1 IQVIA France - RWI, 2 URCEco - Hôpital de l'Hôtel Dieu, Paris France | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | , Budget impact, Economic evaluation | |
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) | ||||
Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C | ||||
Work Environment Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden | ||||
Respiratory Research (2018) 19:12 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0719-x | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
EHR-driven evidence for health and wellness research: Lessons from the NBA | ||||
Mack C, Herzog M, Oakkar E, Shiue K, Meisel P, Dreyer N, DiFiori. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):329-330. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR) | ||||
Lisspers K, Janson C, Larsson K, Johansson G, Telg G, Thuresson M, Ställberg B | ||||
Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. | ||||
Respiratory Medicine 136 (2018) 15–20 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29501242 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
Can patients accurately report their drugs? -A comparison of self-reported medication with a national register in Denmark in a subset of the protect pregnancy cohort. | ||||
Bourke A, Laursen M, Dreyer N, Hallgreen CE, Blackburn S | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):87 |
||||
, Poster | ||||
, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy, Womens Health | 2018 | English | ||
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM | ||||
Bodaghi Charles, Benque Emma, Troubat Arnaud | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Clinical setting: Home care, Pricing & Reimbursement | |
Factors associated with lung cancer in COPD patients | ||||
Sandelin M, Mindus S, Thuresson M, Lisspers K, Ställberg B, Johanson G, Larsson K, Janson C | ||||
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden | ||||
Int J COPD (2018) 2018:13 1833–1839 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.dovepress.com/factors-associated-with-lung-cancer-in-copd-patients-peer-reviewed-fulltext-article-COPD | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Population Based Study, Retrospective cohort analysis | |
Methodologic considerations for non-interventional studies evaluating outcomes of originator-to-biosimilar switching | ||||
Desai R, Kim S, Gagne J, Curtis J, Bosco J, Bradbury B. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2): 4-5 |
||||
, Symposium | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | ||
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR) | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K | ||||
Respiratory, Allergy and Sleep Research, Dept of Medical Sciences, Uppsala University, Uppsala, Sweden | ||||
European Respiratory Journal (2018) 52: 1701927 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/52/2/1701927 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
When and where to use blinding in pragmatic trials. | ||||
Christian J, Brouwer E, Davis K, Bennett D, Dreyer N, Girman C. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):203-204. |
||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | ||
Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR) | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Telg G, Thuresson M, Christensen Nordahl H, Larsson K | ||||
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, 751 85 Uppsala, Sweden | ||||
Respiratory Research (2018) 19:168 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0855-3 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Cost of illness, Observational study, Population Based Study | |
Bringing patient-generated data into pharmacoepidemiology: The who, what, why, where, when and how. | ||||
Dixon WG, Bartels DB, Curtis J, Bourke A, Martin D, Lin KJ. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):22-23. |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2018 | English | ||
ASSESSMENT OF THE UNIT COSTS IN IMAGING ACTS: THE EXAMPLE OF MRI AND CT-SCAN ACTS IN France | ||||
Vasilescu L., Faller M., Allou A. | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology | 2018 | English | , Literature Review, Public Health, Review | |
Lessons learned on enhanced passive safety surveillance of influenza vaccines. | ||||
Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S | ||||
Pharmacoepidemiol & Drug Saf 2018;27(2):495 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | ||
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective | ||||
Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A | ||||
Baker, Subedi: Pfizer; Ferrufino, Kowal and Tan: IQVIA | ||||
ClinicoEconomics and outcomes research |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/pdf/ceor-10-359.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | , Cost benefit | |
The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly | ||||
Miao Jiang; Danny Hughes; Wenyi Wang | ||||
Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar) | ||||
Preventive Medicine |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries | ||||
Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy | ||||
Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA); | ||||
Radiology |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
Total cost of health care resource utilization for asthma patients in Sweden with different exposures to oral corticosteroids | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Christensen H, Larsson K | ||||
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Sweden | ||||
Allergy. European Journal of Allergy and Clinical Immunology, Vol. 73, no Suppl.105, p. 529-529 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://uu.diva-portal.org/smash/record.jsf?pid=diva2%3A1260079&dswid=-316 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Cost analysis | |
A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA | ||||
Wehler EA, Storm M, Kowal S, Campbell C, Boscoe A | ||||
IQVIA | ||||
European Hematology Association |
||||
, Poster | ||||
, USA | ||||
Abstract: https://learningcenter.ehaweb.org/eha/2018/stockholm/215730/michael.storm.a.health.state.utility.model.estimating.the.impact.of.ivosidenib.html?f=ce_id=1346*ot_id=19069*media=3*speaker=664497 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Utility analysis | |
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China. | ||||
Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1 | ||||
1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China | ||||
, Poster | ||||
, China | ||||
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/83455 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Respiratory disease | 2018 | English | , Cost analysis, Cost effectiveness | |
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH PERSISTENT ASTHMA BY ATTAINMENT OF HEALTHCARE EFFECTIVENESS AND DATA INFORMATION SET (HEDIS) MEASURES | ||||
Mosnaim G, Ariely R, Depietro M, Near A, Huang H, Batista A, Lang K | ||||
Huan Huang and Aimee Near are at IQVIA | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)31892-8/abstract | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Population Based Study | |
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China. | ||||
Salem A, Ramos M, Hu H, Zhong H, Lamotte M | ||||
IQVIA, Zaventem, Belgium | ||||
ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan |
||||
, Poster | ||||
, China | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Respiratory disease | 2018 | English | , Cost effectiveness | |
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire | ||||
Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R | ||||
Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain | ||||
Reumatología Clínica 2018; Sep 5. [Epub ahead of print] |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Rheumatology | 2018 | English | , Clinical setting: hospital, Observational study | |
A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D). | ||||
Huang H, Bell K, Gani R, Tugwell C, Eudicone J, Krukas‐Hampel MR | ||||
Huan Huang is at IQVIA | ||||
Am J Manag Care |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/journals/supplement/2018/real-world-evidence-type2-diabetes-sglt2-inhibitors/retrospective-realworld-study-dapagliflozin-vs-oral-antidiabetic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study | |
The cost-effectiveness of physical activity in the management of COPD patients in the UK. | ||||
Ramos M, Lamotte M, Gerlier L, Svangren P, Cases A M, Haughney J | ||||
IQVIA, Zaventem, Belgium | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Respiratory disease | 2018 | English | , Cost effectiveness | |
Real-World Study of Comorbidities and Complications in Relapsed/Refractory Acute Myeloid Leukemia Patients Identified Using a Claims-based Algorithm | ||||
Shahed Iqbal, Aimee Near, Neil Dhopeshwarkar, Huan Huang, Maribel Salas, Kathy Lang | ||||
Huan Huang and Aimee Near are IQVIA authors | ||||
ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management) |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling. | ||||
Ramos M, Foos V, McEwan P, Lamotte M | ||||
IQVIA, Zaventem, Belgium | ||||
ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2018 | English | , Cost effectiveness | |
Real-world Treatment Patterns for Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Immuno-oncology Therapy | ||||
Huan Huang, Rahul Shenolikar, Brian Seal, Jenny Tse, Chakkarin Burudpakdee | ||||
Huan Huang, Jenny Tse and Chakkarin Burudpakdee are IQVIA authors | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)30588-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD | ||||
Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R | ||||
Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel | ||||
ISPOR Europe 2018 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy | ||||
Condition | Year | Language | Analysis type | |
, Nutritional Disorders, Oncology | 2018 | English | , Clinical setting: Home care, Epidemiological study | |
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. | ||||
Palmer AJ1, Si L1, Tew M2, Hua X2, Willis MS3, Asseburg C3, McEwan P4, Leal J5, Gray A5, Foos V6, Lamotte M6, Feenstra T7, 8, O’Connor PC 9, Brandle M 10, Smolen HJ11, Gahn JC11, Valentine WJ12, Pollock RF12, Breeze P13, Brennan A13, Pollard D13, Ye W14, Herman WH15, Isaman DJ14, Kuo S16, Laiteerapong N17, Tran-Duy A2, Clarke PM2 | ||||
1 University of Tasmania, Hobart, Tasmania, Australia 2 University of Melbourne, Melbourne, Victoria, Australia 3 The Swedish Institute for Health Economics, Lund, Sweden 4 Health Economics and Outcomes Research Ltd., Cardiff, UK 5 University of Oxford, Oxford, UK 6 IQVIA, Zaventem, Belgium 7 National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 8 Groningen University, Groningen, The Netherlands 9 HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA 10 Kantonsspital St. Gallen, St. Gallen, Switzerland 11 Medical Decision Modeling Inc., Indianapolis, IN, USA 12 Ossian Health Economics and Communications, Basel, Switzerland 13 University of Sheffield, Sheffield, UK 14 University of Michigan, Ann Arbor, MI, USA 15 University of Michigan, Ann Arbor, MI, USA 16 University of Michigan, Ann Arbor, MI, USA 17 University of Chicago, Chicago, IL, USA | ||||
Value in Health, 2018, 21(6): 724-731 |
||||
, Article | ||||
, International | ||||
Abstract: https://doi.org/10.1016/j.jval.2018.02.002 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2018 | English | , Cost effectiveness | |
A real-world data study regarding hospital resources use and costs associated with melanoma cancer in Spain | ||||
Carmen Barrull, Ángel Baltasar, Daniel Callejo, Vanessa Gómez, Neus Canal, Miriam Solozabal | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-melanoma-cancer-in.pdf?la=en&hash=8C1394471FDDA3956BBF8788628C6443F1E3D5B6 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations. | ||||
Foos V, McEwan P, Lamotte M | ||||
IQVIA, Zaventem, Belgium | ||||
Value in Health, Volume 21, Supplement 1, May 2018, Page S220 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2018 | English | , Cost effectiveness | |
A real-world data study regarding hospital resources use and costs associated with colorectal cancer in Spain | ||||
Laura Planellas, Míriam Solozabal, Carmen Barrull, Anna de Prado, Neus Canal, Vanessa Gómez | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-colorectal-cancer.pdf?la=en&hash=FE374C80DDC224B135913C13D65857DAE36D0007 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Neue Krebstherapeutika: Personalisierte Medizin eröffnet neuartige Therapieoptionen | ||||
Hoyer L , Schmidt L | ||||
IQVIA Frankfurt Germany | ||||
Pharmamind |
||||
, Article | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | German | ||
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review | ||||
Jaume Puig-Junoya,b,c, Natàlia Pascual-Argenteb,c, Lluc Puig-Codinab, Laura Planellasd, Míriam Solozabald | ||||
aDepartment of Economics and Business (UPF), Pompeu Fabra University, Barcelona, Spain; bUPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain; cUPF Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain; dHEOR-RWI, IQVIA Spain | ||||
Expert Review of Gastroenterology and Hepatology. Volume 12, 2018 - Issue 12 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/17474124.2018.1540929?journalCode=ierh20 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2018 | English | , Clinical setting: hospital, Literature Review, Review | |
Persistence with Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in Germany | ||||
Kostev K, Kap EJ | ||||
IQVIA, Frankfurt am Main, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Mental health | 2018 | English | , Database Study, Epidemiological study | |
Hospital resources use and costs associated with 6 prevalent cancer in Spain, a Real World Data study | ||||
Daniel Callejo , Laura Planellas, Míriam Solozabal, Carmen Barrull, Neus Canal, Anna de Prado | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/hospital-resources-use-and-costs-associated-with-6-prevalent-cancers-in-spain-a-real-world-data-stud.pdf?la=en&hash=C28017910D9722573D7A318AB3782530D5F50054 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Studies on Economic Burden of Disease Using Real-World Healthcare Data in Japan: A Systematic Review | ||||
Kuan WY, Demiya S, Yu E, Piao Y | ||||
IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
Value in Health |
||||
, Article | ||||
, Japan | ||||
Abstract: DOI:https://doi.org/10.1016/j.jval.2018.07.391 | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | , Economic evaluation | |
Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data | ||||
Maroun R1,2, Mitrofan L3, Benjamin L1 Nachbaur G1, Maunoury F4 Le Jeunne P3 Durand-Zaleski I2,5 | ||||
1GlaxoSmithKline, Health Economics and Outcomes Research,France 2INSERM, ECEVE, UMR 1123, Paris, France 3IQVIA, La Défense, France 4Statesia, Le Mans, France 5URC-ECO, APHP, Paris, France | ||||
BMC Cancer. 2018; 18: 214. |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822611/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
A real-world data study regarding hospital resources use and costs associated with breast cancer in Spain | ||||
Daniel Callejo , Vanessa Gómez, Míriam Solozabal, Laura Planellas, Ágata Carreño, Ángel Baltasar | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-breast-cancer-in-s.pdf?la=en&hash=8547AD20386AF0B3E1DA95EDA710A7EEF6E40C68 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
The Prescription Patterns of Selective Serotonin (Norepinephrine) Reuptake IInhibitors in Germany | ||||
Kap EJ1, Konrad M2, Bohlken J3, Kostev K1 | ||||
1IQVIA, Frankfurt am Main, Germany, 2FOM University of Applied Sciences, Frankfurt am Main, Germany, 3Praxis für Neurologie und Psychiatrie, Berlin, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Database Study, Epidemiological study | |
A real-world data study regarding hospital resources use and costs associated with bladder cancer in Spain | ||||
Anna de Prado, Ángel Baltasar, Vanessa Gómez, Carme Barrull, Àgata Carreño, Laura Planellas | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-bladder-cancer-in.pdf?la=en&hash=9A2EA74E7E8AEC14E41A2D6DACD80911C716853F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A Comparison of Patient-Reported Outcomes (PRO) Study Between Japan and the United States in Oncology Research: A Systematic Literature Review | ||||
Chand K, Morii J, Sato T | ||||
IQVIA solutions Japan, Tokyo, Japan | ||||
Abstract: DOI:https://doi.org/10.1016/j.jval.2018.07.137 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
The Prevalence of Multimorbidity and Polypharmacy in Elderly Patients Followed in General Practices in Germany | ||||
Kostev K, Kap EJ, Jacob L | ||||
IQVIA, Frankfurt am Main, Germany, University of Paris 5, Paris, France | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2018 | English | , Epidemiological study, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with lung cancer in Spain | ||||
Anna de Prado, Daniel Callejo, Vanessa Gómez, Angel Baltasar, Neus Canal, Carme Barrull | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-lung-cancer-in-spa.pdf?la=en&hash=8F884E874C670E07BCA72315DC3B6E042F558F23 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Harmo an Eletronic Medicine Diary Designed to Manage Data on Prescription at Pharmacies on the Cloud Server and Even More | ||||
Igarashi A1, Demiya S2, Yu E2, Fukushi G3, Takagi Y3 | ||||
1University of Tokyo, Tokyo, Japan, 2IMS Japan K.K., Tokyo, Japan, 3SONY Corp., Tokyo, Japan | ||||
Value in Health |
||||
, Article | ||||
, Japan | ||||
Abstract: DOI:https://doi.org/10.1016/j.jval.2018.07.737 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | , direct to patient research | |
Depression is Associated with Chronic Disorders in Children and Adolescents | ||||
Kostev K, Dombrowski S, Konrad M | ||||
IQVIA, Frankfurt am Main, Germany, FOM University of Applied Sciences, Frankfurt am Main, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Mental health, Pediatrics | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
How a new innovation assessment tool relates to recent drug launches for Spanish National acess | ||||
Míriam Solozabal, Elisabet Viayna, Marta Rubio, Mireia Sumalla, Ane Otermin, David Gasche, Laura Planellas, Daniel Callejo | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-13/how-a-new-innovation-assessment-tool-relates-to-recent-drug-launches-for-spanish-national-access.pdf?la=en&hash=1D16D1D70ADE257D3A09480F1B1EEB002BDE83A4 | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2018 | English | , Clinical setting: hospital, Pricing & Reimbursement | |
Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? | ||||
F Christiaan K Dolk, Koen B Pouwels, David R M Smith, Julie V Robotham, Timo Smieszek | ||||
Public Health England | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with prostate cancer in Spain | ||||
Míriam Solozabal, Anna de Prado, Laura Planellas, Ángel Baltasar, Àgata Carreño, Daniel Callejo | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-prostate-cancer-in.pdf?la=en&hash=1DA52D1BC0EDBFCE32B1DB5C46308CE4E06D318F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care | ||||
David R M Smith,F Christiaan K Dolk, Koen B Pouwels, Morag Christie, Julie V Robotham, Timo Smieszek | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Retrospective database analysis | |
Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain | ||||
Soler-Cataluña JJ1, Fernández Villar A2, Piñera Salmerón PL3, Román-Rodríguez M4, Huerta Hernández A5, Roset Gamisans M6 | ||||
1 Servicio de Neumología, Hospital de Arnau de Vilanova-Lliria, Valencia, España. 2 Servicio de Neumología, Hospital Álvaro Cunqueiro. Instituto de Investigación Biomédica Galicia Sur, Vigo (Pontevedra), España. 3 Servicio de Urgencias, Hospital General Universitario Reina Sofía, Murcia, España. 4 Médico de familia, Centro de Salud Son Pisà, Islas Baleares, Mallorca, España. 5 Departamento de Evaluación de Medicamentos, GlaxoSmithKline, Tres Cantos, Madrid, España. 6 Health Economics and Outcomes Research, IQVIA, Barcelona, España. | ||||
Semergen. 2018 Oct;44(7):449-457 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30206038 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2018 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Observational study | |
"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice" | ||||
"Marcello Arca, David Ansell , Maurizio Averna, Francesca Fanelli, Katherine Gorcyca, Serban R. Iorga, Aldo P. Maggioni, Georges Paizis, Radovan Tomic, Alberico L. Catapano" | ||||
Sanofi | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Retrospective database analysis | |
Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care | ||||
Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Julie V Robotham, Timo Smieszek | ||||
Public Health England | ||||
, Article, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Retrospective database analysis | |
"Risk of chronic kidney disease in young adults with impaired glucose tolerance/ impaired fasting glucose: a retrospective cohort study using electronic primary care records" | ||||
Ferozkhan Jadhakhan, Tom Marshall, Ronan Ryan and Paramjit Gill. | ||||
University of Birmingham | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective database analysis | |
Explaining variation in antibiotic prescribing between general practices in the UK | ||||
Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
Public Health England | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Contemporary real-world evidences on ALK+ NSCLC patients in Italy | ||||
Tucci C1, Trimarchi C1, Urbinati D1, Demma F2, Fico M2, Fioravanti L2 | ||||
1 IQVIA, RWI, Milan, Italy 2 Takeda, Italy | ||||
ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Database Study, Real World Data, Real World Evidence | |
Explaining variation in antibiotic prescribing between general practices in the UK | ||||
Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Explaining variation in antibiotic prescribing between general practices in the UK | ||||
Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Lipid modifying therapy and LDL-C achievements in a very high cardiovascular risk cohort of patients managed by general practitioners in Italy | ||||
Fanelli F1, Gazzi L1, Heiman F2, Peduto I2, Pegoraro V2 | ||||
1 Sanofi SpA, Milan, Italy 2 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21tst Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Patients with idiopathic pulmonary fibrosis (IPF): what happens before the diagnosis? A real-world, retrospective, primary care database analysis | ||||
Cipelli R1, Heiman F1, Acciai V2, Berardo P2, Olivi I2 | ||||
1 IQVIA, RWI, Milan, Italy 2 Boehringer Ingelheim Italia S.p.A, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Characterization of preventive treatment in episodic and chronic migraine patients managed by general practitioners in Italy | ||||
Pegoraro V1, Heiman F1, di Nola L2, Pulimeno S2, Burgio L2 | ||||
1 IQVIA, RWI, Milan, Italy 2 Teva Italia Srl, Assago, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Pain | 2018 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Explaining variation in antibiotic prescribing between general practices in the UK | ||||
Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Lipid modifying therapy and LDL-C achievements in a very high cardiovascular risk cohort of statin intolerant patients managed by general practitioners in Italy | ||||
Gazzi L1, Fanelli F1, Heiman F2, Di Filippo A2, Pegoraro V2 | ||||
1 Sanofi SpA, Milan, Italy 2 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Explaining variation in antibiotic prescribing between general practices in the UK | ||||
Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
A cost estimation of management of allergic asthma in Italy | ||||
Ariemma F1, Trimarchi C1, Canonica GW2, Senna G3, Scichilone N4, Pelaia G5, Paggiaro P6, Griffiths S7, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy 2 Humanitas Research Hospital, Milan, Italy 3 Azienda Ospedaliera Universitaria Integrata, Verona Italy 4 Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy 5 Azienda Ospedaliera Universitaria Mater Domini, Catanzaro, Italy 6 Azienda Ospedaliero Universitaria, Pisa, Italy 7 Alk Abellò, Milan Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Cost analysis, Real World Data, Real World Evidence, Retrospective cohort analysis | |
Potential for reducing inappropriate antibiotic prescribing in English primary care | ||||
Timo Smieszek, Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Susan Hopkins, Mike Sharland, Alastair D Hay, Michael V Moore, Julie V Robotham | ||||
Public Health England | ||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Retrospective database analysis | |
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study | ||||
Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW | ||||
StatFinn & EPID Research, Espoo, Finland | ||||
Endocrinol Diabetes Metab. |
||||
, Article | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
Emerging trends in the management of NSCLC PD-L1+ patients in Italy | ||||
Trimarchi C1, Arenga A1, De Santo E1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Database Study, Real World Data, Real World Evidence | |
Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG | ||||
Fischer T, Bonduelle D, Antoni B | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2018 | German | , Market impact | |
Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls | ||||
Mittendorfer-Rutz E, Rahman S, Tanskanen A, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Taipale H, Tiihonen J | ||||
EPID Research Oy, Espoo, Finland | ||||
Schizophr Bull. |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://academic.oup.com/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sby130/5090132?redirectedFrom=fulltext | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Population Based Study, Retrospective database analysis | |
The impact of the new innovative algorithm in Italy | ||||
Rova A1, Cioni L1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Public Health, Regulatory | 2018 | English | ||
Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considerend by Federal Joint Committee for Determing the Appropriate Comparator? | ||||
Scheler E, Stratil AS, Roxlau T, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Health policy | 2018 | German | , Review | |
The evolution of standard monitoring registries in the Italian market | ||||
Cioni L1, Rova A1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Public Health, Regulatory | 2018 | English | ||
Success Factors for §137h SGB V Assessment of Medical Devices in Germany | ||||
Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2018 | English | , Review | |
Cost-offsets associated with the new triplets available for the treatment of relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice | ||||
Ripellino C1, Peduto I2, Heiman F2, Fioravanti L3, Rea M3, Demma F3 | ||||
1 HEOR Consultant Freelance, Milan, Italy 2 IQVIA, RWI, Milan, Italy 3 Takeda Italia S.p.a., Rome, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Cost analysis, Economic evaluation | |
Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment | ||||
Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria | ||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Pricing and reimbursement | 2018 | English | , Pricing & Reimbursement, Review | |
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases | ||||
Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement | 2018 | English | , Cost analysis, Pricing & Reimbursement | |
Non-persistence risk and health care resource utilization of Italian patients with non-valvular atrial fibrillation | ||||
Cataldo N1, Pegoraro V1, Ripellino C2, Bertasi V3, Di Turi R4, Pastorello M5, Gambera M6 | ||||
1 IQVIA, RWI, Milan, Italy 2 RWE HEOR Consultant, Milan, Italy 3 Azienda ULSS 22 Bussolengo, Italy 4 ASL Roma 3, italy 5 ASP di Palermo, Italy 6 ATS di Bergamo, Italy | ||||
Recenti Prog Med. 2018 Feb;109(2):113-121 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Non-persistence+risk+and+health+care+resource+utilization+of+Italian+patients+with+non-valvular+atrial+fibrillation | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
DERMATOLOGY AS AN EXAMPLE Originator and Generic Market Access Pretection Strategies in Germany Using Dermatology as an Example | ||||
Greiner RA, Antoni B, Batscheider A, Bonduelle D Roxlau T, Stratil AS | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics | 2018 | English | , Market impact | |
Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy | ||||
Malfertheiner P1, Ripellino C2, Cataldo N3 | ||||
1 Klinik für Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke Universität, Magdeburg, Germany 2 2HEOR Consultant Freelance, Milan, Italy 3 IQVIA, RWI, Milan, Italy | ||||
Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586 |
||||
, Article | ||||
, Germany, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29457309 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2018 | English | , Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany | ||||
Gohlke A, Kostev K, Kuschel AS | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pediatrics, Regulatory | 2018 | English | , Utility analysis | |
Duration of Inability to Work in Depression Patients Treated in General or Psychiatric Practices in Germany | ||||
Kostev K, Dombrowski S, Konrad M, Bohlken J | ||||
IQVIA, Frankfurt am Main, Germany FOM University of Applied Sciences, Frankfurt am Main, Germany Praxis für Neurologie und Psychiatrie, Berlin, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Mental health | 2018 | English | , Real World Data, Retrospective cohort analysis | |
Early Insights into the Characteristics and Evolution of Clinical Parameters in a Cohort of Patients Prescribed Sacubitril/Valsartan in Germany | ||||
Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S. | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Schwindeldiagnosen in HNO-Praxen in Deutschland -Demografische Daten und Saisonale Variation | ||||
Seidel DU, Kostev K, Sesterhenn A | ||||
Condition | Year | Language | Analysis type | |
2018 | German | |||
Persistence and Compliance Amongst Sacubitril/Valsartan Patients in Germany, a Retrospective Cohort Study a Longitudinal Pharmacy Database | ||||
WIRTA SB WACHTER R, BALAS B, KLEBS S, FONSECA AF, PROENCA CC, DWORAK M, SCHLIENGER R, ENGELHARD J, MAIER T, KOSTEV K | ||||
Wirta SB, Wachter R, Balas B, Klebs S, Fonseca AF, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Kostev K | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective cohort analysis | ||
Comparative effectiveness of uterine fibroids procedures using linked medical record and claims data | ||||
Aaron B Mendelsohn, Emma Brinkley, Kristina M Franke, Kathy Lang, Evan R Myers & Priscilla Velentgas | ||||
IQVIA; Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, NC 27710, USA | ||||
, Article | ||||
, USA | ||||
Abstract: https://www.futuremedicine.com/doi/full/10.2217/cer-2018-0049 | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2018 | English | ||
Concomitant use of Heart Failure Medication AMongst Patients with Sacubitril/Valsartan Therapy in Germany, A Retrospective Cohort Study Using a Longitudinal Pharmacy Database | ||||
Wachter R, Fonsenca AF, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Kostev K | ||||
, Conference | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | German | , Retrospective cohort analysis | |
Real-World Titration and Treatment Patterns of Sacubitril/Valsartan in Germany, Retrospective Cohort Study Using a Longitudinal Pharmacy Database | ||||
Wachter R, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Klostev K | ||||
, Conference | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective cohort analysis | ||
Changes in Patient Characteristics, Glucose Lowering Treatment, Glycemic Control and Complications in Type 2 Diabetes in General Practices (Disease Analyzer, Germany: 2008-2016) | ||||
Rathmann W, Scheerer M, Rohwedder K, Busch S, Kostev K | ||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | ||
Increased Depression Symptom Score in Newly Diagnosed Type 2 Diabetes Patients | ||||
Rathmann W, Engelhard J, ANderson D, Kostev K, Zou M, Busch S, Kuss O, Hahn M | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Mental health | 2018 | English | ||
Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Monitoring in Patients Affected by Hypertension - A Retrospective Study with 176.565 Patients in Germany | ||||
Jacob L, Seitz F, Kostev K | ||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Retrospective cohort analysis | |
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden. | ||||
, Article | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Rare disease | 2018 | English | , Retrospective database analysis | |
Persistence with Antihypertensive Drugs in Hypertension Patients with Depression in Germany | ||||
Jacob L, Kostev K | ||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | ||
Predictors of Overall Survival for Multiple Myeloma Patients Depending on Transplant Status According to a Retrospective, Non-Interventional Study in Norway | ||||
Fredrik H. Schjesvold, MD PhD, Anderson Jenna, Jaak Sõnajalg, Amy Leval, PhD, Anna Lysén, MSc, Saeeda Rana, Päivi Castren-Kortekangas, Fredrik Borgsten | ||||
Fredrik H. Schjesvold - Oslo University; Jenna Anderson - EPID Research (now part of IQVIA); Jaak Sõnajalg - EPID Research (now part of IQVIA). | ||||
Blood (2018) 132 (Supplement 1): 5759. |
||||
, Abstract | ||||
, Norway | ||||
Abstract: https://ashpublications.org/blood/article/132/Supplement%201/5759/263137/Predictors-of-Overall-Survival-for-Multiple | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Observational study, Population Based Study | |
PREVALENCE AND TREATMENT OF SEXUALLY TRANSMITTED DISEASES IN GYNECOLOGICAL PRACTICES IN GERMANY- A RETROSPECTIVE STUDY WITH MORE THAN 1,000,000 PATIENTS | ||||
Prevalence and Treatment of Sexuality Transmitted Diseases in Gynecological Practices in Germany - A Retrospective Study with more than 1,000,000 Patients | ||||
INT J CLIN PHARMACOL THER. 2018 FEB 2. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2018 | German | , Retrospective cohort analysis | |
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis | ||||
Ostacher M1, Ng-Mak D2, Patel P3, Ntais D4, Schlueter M4, Loebel A5 | ||||
1 Department of Psychiatry and Behavioral Sciences , Stanford University School of Medicine , Palo Alto , CA , USA. 2 Global HEOR, Sunovion Pharmaceuticals Inc , Marlborough , MA , USA. 3 Health Outcomes, Kantar Health , New York , NY , USA. 4 Real-World Evidence Solutions, QuintilesIMS , London , UK. 5 Sunovion Pharmaceuticals Inc , Fort Lee, NJ , USA | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Retrospective database analysis | |
Frequency of Thyroid-Stimulating Hormone Monitoring in Patients After Thyroidectomy: A Retrospective Study in Primary Care Practices in Germany | ||||
Kostev K, Winiarski M,Schüller L, Sesterhenn Am, Jacob L | ||||
EXP CLIN ENDOCRINOL DIABETES. 2018 FEB 2. |
||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective cohort analysis | ||
Seasonal Variation of Epistaxis in Germany | ||||
Seidel DU, Sesterhenn AM, Kostev K | ||||
J CRANIOFAC SURG. 2018 FEB 12. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices | ||||
Muigai J, Jacob L, Klostev K, Kalder M | ||||
ONCOTARGET. 2018 JAN 3;9(9):8725-8730 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Womens Health | 2018 | English | ||
Trends in Incidence of ACL Reconstruction and Concomitant Procedures Among Commercially-Insured Individuals in the United States, 2002-2014. | ||||
Herzog MH, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT. | ||||
Sports Health. 2018. Accepted. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
Diagnoses of Dizziness- and Vertigo-Related in ENT Practices in Germany | ||||
Seidel DU, Park JJH, Sesterhenn AM, Kostev K | ||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2018 | English | ||
Higher Rates of Lower Extremity Injury on Synthetic Turf compared to Natural Turf Among National Football League Athletes: Epidemiologic Confirmation of a Biomechanical Mechanism. | ||||
Mack CM, Hershman E, Anderson R, Coughlin M, McNitt A, Sendor RJ, Kent R. | ||||
American J of Sports Medicine. 2018. AJSM. In press. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
Diagnosis and Treating Dementia in German Primary and Specialized Care Between 2011 and 2015 | ||||
Michalowsky B, Kostev K, Iliffe S, Hoffmann W, Bohlken J | ||||
INT J CLIN PHARMACOL THER. 2018 APR 27. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2018 | English | ||
A close look at Synthetic Turf: History, Design, Maintenance and Athlete Safety. | ||||
Jastifer J, Anderson R, Coughlin M, McNitt A, Mack CM, Kent R. | ||||
Sports Health. 2018. In press. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients | ||||
Kostev K, Lucas A, Jacob L | ||||
EXP CLIN ENDOCRINOL DIABETES. 2018 MAR 12. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Metabolic Disorders , Vascular disease | 2018 | English | , Retrospective cohort analysis | |
Inzidenz und Behandlung des Nicht Stoffgebundenen Delirs in Deutschen Haus- und Facharztpraxen | ||||
Bohlken J, Hewer W, Kostev K | ||||
Condition | Year | Language | Analysis type | |
2018 | German | |||
Impact of Tobacco Smoking on the Risk of Developing 25 Different Cancers in the UK: A Retrospective Study of 422,010 Patients Followed for up to 30 Years | ||||
Jacob L, Freyn M, Kalder M, Dinas K, Kostev k | ||||
ONCOTARGET. 2018 APR 3;9(25):17420-17429 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective cohort analysis | |
Association Between Gout and Osteoporosis Risk in the United Kingdom | ||||
Kostev K | ||||
OSTEOPOROS INT. 2018 APR 10. |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Basic characteristics and representativeness of the German Disease Analyzer Database | ||||
Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. | ||||
Institute of Biometrics, Epidemiology, German Diabetes Center, Düsseldorf, Real World Insights, IQVIA, Frankfurt, Germany | ||||
Int J Clin Pharmacol Ther. 2018 Aug 31. doi: 10.5414/CP203320 . |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Basic+characteristics+and+representativeness+of+the+German+Disease+Analyzer+Database%E2%80%A9. | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2018 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective cohort analysis | |
Association of Laryngeal Cancer with Vocal Cord Leukoplakia and related Risk Factors in 1,184 Patients Diagnosed in Otorhinolaryngology Practices in Germany | ||||
Kostev K, Jacob L, Kalder M, Sesterhenn AM, MDD, Seidel DU | ||||
MOL CLIN ONCOLOGY 2018; 8: 689-693, 2018 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
The Impact of Non-Persistence in the Direct and Indirect Costs in Patients Treated with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Germany | ||||
Ziegelbauer K, Kostev K, Hübinger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S | ||||
RHEUMATOLOGY (OXFORD). 2018 APR 12 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Prevalence and Treatment of Sexually Transmitted Infections in Men Followed by Urologists in Germany- A Cross Sectional Study with 347,090 Men | ||||
Jacob L, Duse DA, Kostev K | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2018 | English | ||
Prevalence and Prescribed Drugs for Treatment of Vulvovaginal Candidiasis in Gynecological Practices in Germany: A Retrospective Study of 954,186 Patients | ||||
Jacob K, John M, Kalder M, Kostev K | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2018 | English | , Retrospective cohort analysis | |
Time Between Suspected and Confirmed Diagnosis of Crohn's Disease and Ulcerative Colitis in Patients Followed in Gastroenterological Practices in Germany | ||||
Jacob K, Konrad M, Kostev K | ||||
INT J COLORECTAL DIS. 2018 MAY |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2018 | English | ||
Diagnoses of Suspected Cancer in Otolaryngology Practices in Germany | ||||
Kostev K, Lasrich M, Schüller L, Diogo I, Sesterhenn A, Jacob L | ||||
MOL CLIN ONCOLOGY |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Association Between Sleep Disorders and the Presence of Breast Cancer Metastases in Gynecological Practices in Germany: A Case-Control Study of 11,412 Women | ||||
Jacob L, Schloten PC, Kostev K, Kalder M | ||||
BREAST CANCER RES TREAT. 2018 MAY 29. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2018 | English | ||
The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany | ||||
Bohlken J, Jacob L, Van Den Bussche H, Kostev K | ||||
J ALZHEIMERS DIS. 2018 JUN 6. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2018 | English | ||
Relevance of Coded Prodromal MCI in the Future Routine Treatment of Patients with Dementia in Germany | ||||
Bohlekn J, Kostev K | ||||
J ALZHEIMERS DIS. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2018 | English | ||
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study | ||||
John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Carter Thorne MD, FRCPC 3, Neil H. Shear MD, FRCPC 4, 5, Gerald Lebovic PhD 6, 7, Sebastien K. Gerega MBA 8, Brad Millson MBS 8, Driss Oraichi PhD 8, Tania Gaetano B.Comm, MIS 9, Sandra Gazel MBA, MSc 9, Martin G. Latour PhD 9, Marie-Claude Laliberté PhD 9 | ||||
1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Southlake Regional Health Centre, Newmarket, Ontario, Canada 4 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 5 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 6 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 7 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 8 QuintilesIMS, Kirkland, Quebec, Canada 9 AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
Clinical Therapeutics, Volume 40, Issue 3 pages 415-429.e6 |
||||
, Canada | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S014929181830050X?via%3Dihub#! | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Observational study, Retrospective cohort analysis | |
Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany | ||||
Kostev K, Hadji P, Jacob L | ||||
J ALZHEIMERS DIS. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2018 | English | ||
Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study | ||||
Louis BessetteEmail author, Gerald Lebovic, Brad Millson, Katia Charland, Krishna Donepudi, Tania Gaetano, Valencia Remple, Martin G. Latour, Sandra Gazel, Marie-Claude Laliberté, Carter Thorne | ||||
1. Department of Medicine, Laval University, Quebec, Canada 2. Applied Health Research Centre, St. Michael’s Hospital, Toronto, Canada 3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada 4. QuintilesIMS, Quebec, Canada 5. AbbVie Corporation, Quebec, Canada 6. Southlake Regional Health Centre, Newmarket, Canada | ||||
Rheumatology and Therapy, June 2018, Volume 5, Issue 1, pages 75-85 |
||||
, Canada | ||||
Abstract: https://link.springer.com/article/10.1007/s40744-018-0109-3 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Longitudinal study | |
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients with Nonvalvular Atrial Fibrillation Treated in Routine German Practice | ||||
Oleman CI, Peacock WF, Antz M | ||||
HEART LUNG CIRC. 2018 MAR;27(3):390-393 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | ||
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study | ||||
John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Neil H. Shear MD, FRCPC 3, 4, Gerald Lebovic PhD 5, 6, Jennifer Glass PhD 7, Brad Millson MBS 7, Tania Gaetano BComm, MIS 8, Sandra Gazel MBA, MSc 8, Martin G. Latour PhD 8, Marie-Claude Laliberté PhD 8, J. Carter Thorne MD, FRCP 5, 6 | ||||
1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 4 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 5 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 QuintilesIMS, Health Access and Outcomes, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
, Canada | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S014929181830184X?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Longitudinal study, Retrospective cohort analysis | |
Assessing the Benefits of Co-pay Card Usage Among Diabetic Patients in Canada | ||||
Jing Guo 1, Christian Silva 1, Chris Stewart 1, Andrew Leung 1, Behlool Khan 2, Johanna Mancini 2 | ||||
1 Department of Mechanical and Industrial Engineering, University of Toronto 2 IQVIA | ||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/frontiers-2018-final-poster-for-presentation.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective cohort analysis | |
Cost-Effectiveness Analysis of Brodalumab in Moderate-to-Severe Plaque Psoriasis in Canada | ||||
Xue, W. 1, Gray, E. 1, Khoudigian-Sinani, S. 2, Barbeau, M. 3, Frieder, D. 3 | ||||
1 IQVIA, London, UK, 2 IQVIA Mississauga, ON, Canada, 3 Valeant Canada LP, Laval QC, Canada | ||||
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/valeantbrodalumab-cem-poster-ispor-final.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2018 | English | , Database Study | |
Efficacy of Brodalumab in the Treatment of Moderate-to-Severe Psoriasis: A Network Meta-Analysis | ||||
Xue, W. 1, Saharia, P. 2, Gray, E. 1, Khoudigian-Sinani, S. 3, Barbeau, M. 4, Frieder, D. 4 | ||||
1. IQVIA, London, UK, 2. IQVIA Gurugram, India, 3. IQVIA Mississauga, ON, Canada, 4. Valeant Canada LP, Laval QC, Canada | ||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/valeantbrodalumab-nma-poster-ispor-final.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2018 | English | , Meta analysis | |
Exploring patterns of palivizumab prescribing in English hospitals using linked hospital admissions and pharmacy datasets | ||||
Zylbersztejn A, Hardelid P | ||||
IQVIA/Public Health England | ||||
, Abstract, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | ||
Antibiotic Therapy in Children with Otitis Media in ENT Specialists and Pediatricians | ||||
Kostev K, Dombrowski S, Seidel DU | ||||
IQVIA, Frankfurt am Main, Germany Städtisches Klinikum Solingen, Solingen, Germany | ||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Pediatrics | 2018 | English | ||
Translating clinical guidelines into electronic health records criteria to identify patients eligible for treatment | ||||
Zylbersztejn A, Hardelid P | ||||
IQVIA/UCL | ||||
, Oral communication | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Retrospective database analysis | |
pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA: RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY | ||||
Minhas, Jagdeep, M.Biotech 1; Iqbal-Khan, Sarah, MBA 2; Laforty, Callahan, MSc 2; Millson, Brad, MBS 1 | ||||
1 1 Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8 2 Health Access and Outcomes, IQVIA, 6755 Century Avenue, Mississauga, ON, L5N 6A4 | ||||
2018 CADTH Symposium, April 15-17, 2018, Halifax, NS, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/pcpa-changes-cadth-2018-poster-print.pdf | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2018 | English | , Observational study | |
Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to PMPRB12 has on Canadian Product List Prices | ||||
van Doorn-Drennan, J. 1, Minhas, J. 1, Millson, B. 1, McCormick, J. 1 | ||||
1 IQVIA, Kanata, ON, Canada | ||||
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA |
||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/pmprb-ispor-poster-print.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | ||
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada | ||||
1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada | ||||
1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada | ||||
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/nn-ispor-poster-may-2018.pdf | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2018 | English | , Retrospective cohort analysis | |
Longitudinal Study of Patient Profile and Treatment Patterns of Omalizumab in Patients with Asthma Refractory to Inhaled Medications | ||||
Jason K. Lee 1, Suvina Amin 2, Michelle Erdmann 2, Atif Kukaswadia 3, Jelena Ivanovic 3, Aren Fischer 3, Alain Gendron 2,4 | ||||
1 Evidence Based Medical Educator Inc. Toronto, On, Canada and Section Head of Asthma at Canadian Society of Allergy and Clinical Immunology; 2 AstraZeneca, Mississauga, ON, Canada; 3 IQVIA, Toronto, ON, Canada; 4 Department of medicine, University of Montreal, Montreal, Canada | ||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Longitudinal study, Retrospective cohort analysis | |
Persistence with Insulin Glargine 300 lU/mL compared to other Basal Insulins: A Canadian Retrospective Cohort Study | ||||
Kobina Quansah 1, Luc Sauriol 2, Atif Kukaswadia 1, Samantha Bremner 3, Bradley Millson 3 | ||||
1 IQVIA, Mississauga, ON, Canada, 2 Sanofi, Laval, QC, Canada, 3 IQVIA, Kanata, ON, Canada | ||||
ADA 2018, June 22-26, 2018, Orlando, FL |
||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective cohort analysis | |
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes | ||||
Mocarski M, Yeaw J, Divino V, DeKoven M, Guerrero G, Langer J, Thorsted BL | ||||
Novo Nordisk, IQVIA | ||||
J Manag Care Spec Pharm |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.jmcp.org/doi/10.18553/jmcp.2017.17218 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Utility analysis | |
Two-year adherence and costs for biologic therapy for rheumatoid arthritis | ||||
Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J | ||||
Amgen, IQVIA | ||||
Am J Manag Care |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/journals/issue/2018/2018-vol24-sp8/twoyear-adherence-and-costs-for-biologic-therapy-for-rheumatoid-arthritis?p=1 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2018 | English | , Cost analysis, Retrospective cohort analysis | |
The economic burden of CIDP in the United States: A case-control study. | ||||
Divino V, Mallick R, DeKoven M, Krishnarajah G | ||||
IQVIA; CLS Behring | ||||
Journal. PLoS One. 2018 Oct 23;13(10):e0206205. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30352101 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Cost of illness, Retrospective database analysis | |
Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus | ||||
Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER | ||||
AstraZeneca, IQVIA | ||||
Lupus |
||||
, Article | ||||
, USA | ||||
Abstract: http://journals.sagepub.com/doi/abs/10.1177/0961203318790675?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | , Cost analysis, Retrospective cohort analysis | |
Impact of overactive bladder symptoms on work activity: the ACTIVHA study | ||||
Rapariz M1, Mora AM2, Roset M3. | ||||
1, Servicio de Urología, Hospital de Gran Canaria Dr. Negrín, Gran Canaria, España 2,Astellas Pharma, Madrid, España 3, Real World Insights, QuintilesIMS, Barcelona, España | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2018 | Spanish | ||
The Impact of Risk Minimization Measures on Compliance and Prescribing Practices of Flupirtine in Germany. | ||||
Kaplan S, Ehlken B, Hamann X | ||||
Teva Pharmaceutical Industries Ltd , Petach Tikva , Israel. IQVIA (formerly IMS Health) , Munich , Germany. Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany | ||||
Curr Med Res Opin |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Medication compliance | 2018 | English | , Retrospective cohort analysis | |
Dutch health state utilities for infertility and subfertility. | ||||
Krol M, Nap A, Michels RM, Veraart CPWM, Goossens LMA | ||||
IQVIA, Netherlands | ||||
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
, Abstract | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes | 2018 | English | , Quality of life, Utility analysis | |
Cost effectiveness of cladribine tablets for treatmetn of RMS in The Netherlands. | ||||
De Francesco M1, Mahajan K2, Michels R3, Schiffers K4, Budhia S5, Harty G5, Krol M3 | ||||
1 IQVIA, Zaventem, Belgium 2 IQVIA, India Michels 3 IQVIA, Netherlands 4 Merck, Netherlands 5 Merck, UK | ||||
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
, Abstract | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2018 | English | , Cost effectiveness, Cost utility | |
Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study. | ||||
Buijs S1, Krol M2, de Voer G3 | ||||
1 Healthcare Insights, Netherlands 2 IQVIA, Netherlands 3 Merck, Netherlands | ||||
Journal of Comparative Effectiveness Research, 2018, Vol. 7, No. 5 |
||||
, Article | ||||
, Netherlands | ||||
Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2017-0077 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2018 | English | , Cost of illness | |
Anti-VEGF dosing intervals in patients with neovascular age-related macular degeneration: a retrospective cohort study in Australia | ||||
Skelly A1, Rodriguez Torres L1, Griner R2, Bezlyak V1, Kap E2, Sagkriotis A1 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IQVIA, Cambridge, Massachusetts, USA 3 IQVIA, Frankfurt, Germany | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, 2018, Baltimore, US |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study, Observational study, Retrospective cohort analysis | |
A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom | ||||
Raluy-Callado M, Cox A, MacLachlan S, Bakheit AM, Moore AP, Dinet J & Gabriel S | ||||
Evidera | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | , Retrospective database analysis | |
Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010–2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G. | ||||
Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire | ||||
2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare Diseases | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective database analysis | |
Treatment Patterns, Adherence, and Persistence among Psoriasis Patients Treated with Biologics in a Real-World Setting, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: cBrigham and Women’s | ||||
Journal of Dermatological Treatment |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/09546634.2018.1479725?journalCode=ijdt20 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice" | ||||
Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R & Catapano AL | ||||
Sanofi | ||||
Atherosclerosis |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Retrospective database analysis | |
Healthcare Resource Utilization and Costs among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: Harvard Medical School; Araujo AB: Eli Lilly and Company | ||||
Journal of Medical Economics |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1080/13696998.2018.1472097 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Patient Registries & Real-World Study Methods, Pricing and reimbursement | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Database Analysis of Venous Thromboembolism Treatment Patterns in Inpatients vs Outpatient Settings | ||||
Woodcroft KJ, Phillips S, Maranzano G, Caberwal H | ||||
Woodcroft KJ: Henry Ford Health System; Phillips S: IQVIA; Maranzano G: Boehringer Ingelheim Pharmaceuticals; Caberwal H: Boehringer Ingelheim Pharmaceuticals | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe | ||||
Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA | ||||
Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Denmark, Finland, Germany, Norway, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review | |
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study | ||||
Ali AK, Toussi M, Phillips S, Roste M | ||||
Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug Utlization Study, Drug Utlization Study | 2018 | English | , Database Study, Epidemiological study | |
Identifying the confuonders that explain the difference in readouts between non-interventional and randomized controlled trials: the case of treatments in neovascular age-related macular degeneration | ||||
Sakriotis A1, Griner R2, Durus A1, Doyle OM2, Rodriguez-Torres L1, Wintermantel T2, Clemens A13 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. IQVIA Real World Insights, Switzerland/UK/US; 3. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Australia, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Non-Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Identifying the confuonders that explain the difference in readouts between non-interventional and randomized controlled trials: the case of treatments in neovascular age-related macular degeneration | ||||
Sakriotis A1, Griner R2, Durus A1, Doyle OM2, Rodriguez-Torres L1, Wintermantel T2, Clemens A13 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. IQVIA Real World Insights, Switzerland/UK/US; 3. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Measuring Colorectal Cancer Screening Rates in a US Administrative Claims Database | ||||
Carrington CM, Johnson KE, Fedwa S, Wiatrek S, Lombardo J, Pirolli M, Oliveria SA | ||||
Carrington CM: IQVIA; Johnson KE: IMPAQ International; Fedwa S: American Cancer Society, Atlanta GA; Wiatrek S: American Cancer Society, Austin TX; Lombardo J: American Cancer Society Philadelphia PA; Pirolli M: American Cancer Society Philadelphia PA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource | ||||
Perera G, Pedersen L, Ansell D, Alexander M, Arrighi HM, Avillach P, Foskett N, Gini R, Gordon MF, Gungabissoon U, Mayer MA, Novak G, Rijnbeek P, Trifirò G, van der Lei J, Visser PJ & Stewart R | ||||
The European Medical Information Framework | ||||
Alzheimer’s & Dementia |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Retrospective database analysis | |
Demographic Characteristics and Treatment Patterns among Patients Treated for Hereditary Angioedema in a U.S. Cohort, 2006-2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G | ||||
Tachdjian R: UCLA School of Medicine (Department of Medicine and Pediatrics), Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire. | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies | ||||
Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K | ||||
Wu JW: Analysis Group; Secrest MH: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes, Oncology | 2018 | English | , Database Study, Retrospective cohort analysis, Retrospective database analysis | |
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records | ||||
Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C | ||||
Seqirus | ||||
Pharmacoepidemiology and Drug Safety |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Dermatology, Drug Utlization Study, Urology | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US population. | ||||
Blonde L, Burudpakdee C, Divino V, Bookhart B, Cai J, Pfeifer M, Coleman CI. | ||||
Ochsner Medical Center, Hartford Hospital Evidence-Based Practice Center, Janssen Scientific Affairs, Janssen Medical Affairs, IQVIA | ||||
Curr Med Res Opin. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29671627 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective database analysis | |
TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES | ||||
Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M | ||||
Eli Lilly, IQVIA | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, Belgium, Canada, France, Germany, Italy, Netherlands | ||||
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective database analysis | |
Brain-CODE: A Secure Neuroinformatics Platform for Management, Federation, Sharing and Analysis of Multi-Dimensional Neuroscience Data | ||||
41. Anthony L. Vaccarino, Moyez Dharsee, Stephen Strother, Don Aldridge, Stephen R. Arnott, Brendan Behan, Costas Dafnas, Fan Dong, Kenneth Edgecombe, Rachad El-Badrawi, Khaled El-Emam, Tom Gee, Susan G. Evans, Mojib Javadi, Francis Jeanson, Shannon Lefaivre, Kristen Lutz, F. Chris MacPhee, Jordan Mikkelsen, Tom Mikkelsen, Nicholas Mirotchnick, Tanya Schmah, Christa M. Studzinski, Donald T. Stuss, Elizabeth Theriault and Kenneth R. Evan | ||||
Frontiers in Neuroinformatics, May, 2018 |
||||
Condition | Year | Language | Analysis type | |
2018 | English | , De-identification / anonymisation | ||
Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: prespecified analyses and reanalysis | ||||
42. N. Persaud, C. Meaney, K. El Emam, R. Moineddin, K. Thorpe | ||||
PLOS ONE, 13(1): e0189978, January 2018 |
||||
Condition | Year | Language | Analysis type | |
2018 | English | , De-identification / anonymisation | ||
Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study. | ||||
Sepassi A, Chingcuanco F, Gordon R, Meier A, Divino V, DeKoven M, Ben-Joseph R. | ||||
Skaggs School of Pharmacy and Pharmaceutical Sciences , University of California; Department of Anesthesiology , UC San Diego Health System; Millennium Health; IQVIA | ||||
J Med Econ |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29480088 | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine, Surgery | 2018 | English | , Retrospective database analysis | |
Wound care treatment patterns for diabetic foot ulcers in a General Practice database in the UK | ||||
80. Catrina Richards, Annette Blackman, Sonia Panesar, Greg Curran, Christine Henry, Christen Gray | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Big data and pharmacovigilance: Data mining for adverse drug events and interactions | ||||
C. Lee Ventola MS | ||||
P T. 2018;43(6): 340-351. |
||||
Condition | Year | Language | Analysis type | |
2018 | English | , Methodology | ||
Incidence of Nd:YAG capsulotomy following single-piece monofocal acrylic IOLs implantation: a retrospective real world evidence study in the UK | ||||
Mukesh Dhariwal, Christine Bouchet, Derek OBoyle, Javeed Khan, Alessandra Venerus, Anushini Muthutantri | ||||
"1GlaxoSmithKline, Brentford, Middlesex, UK 2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK 3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK 4IQVIA, London, UK 5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK 7INSIGNEO, University of Sheffield, Sheffield, UK" 1 Queen’s University of Belfast Royal Victoria Hospital, Belfast, Ireland 2 University Hospitals Bristol National Health Service Foundation Trust, Bristol, United Kingdom 3 Gloucestershire Eye Unit, Cheltenham General Hospital, Cheltenham, United Kingdom 4 Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom 5 Department of Ophthalmology, UC Davis Medical Center, Sacramento, CA, USA 6 Genentech, Inc., South San Francisco, CA, USA Alcon, Novartis, IQVIA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Retrospective database analysis | |
Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration | ||||
Chakravarthy U1, Bailey CC2, Johnston RL3, McKibbin M4, Khan RS5, Mahmood S6, Downey L7, Dhingra N8, Brand C9, Brittain CJ10, Willis JR11, Rabhi S12, Muthutantri A12, Cantrell RA10 | ||||
1 Queen’s University of Belfast Royal Victoria Hospital, Belfast, Ireland 2 University Hospitals Bristol National Health Service Foundation Trust, Bristol, United Kingdom 3 Gloucestershire Eye Unit, Cheltenham General Hospital, Cheltenham, United Kingdom 4 Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study | |
Validation of the Spanish version of the Bladder Pain/Interstitial Cystitis-Symptom Score (BPIC-SS) questionnaire. A useful tool for the diagnosis of bladder pain syndrome | ||||
S. Arlandis, A. Franco, A.M. Mora, P. Rebollo | ||||
Hospital Universitario y Politcnico La Fe, Valencia, Spain Hospital Universitario Clnic, Barcelona, Spain Departamento Mdico, Astellas Pharma S.A., Madrid, Spain Health Economics & Outcomes Research, Real-World Evidence Solutions, QuintilesIMS, Barcelona, Spain | ||||
Actas Urol Esp. 2018;42(7):457-464 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.elsevier.es/en-revista-actas-urologicas-espanolas-english-392-articulo-validation-spanish-version-bladder-pain-interstitial-S2173578618300933 | ||||
Condition | Year | Language | Analysis type | |
, Urology, Womens Health | 2018 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Use of real world EMR data in ophthalmology: Case example on development and validation of disease definition algorithms using a large database in the UK | ||||
Alessandra Venerus1, Anushini Muthutantri1, Ian Bonzani1, Usha Chakravarthy2 | ||||
"1 IQVIA, London, United Kingdom 2 Queen’s University of Belfast Royal Victoria Hospital, Belfast, Ireland" | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Incidence of Nd:YAG capsulotomy following single-piece monofocal acrylic IOLs implantation: a retrospective real world evidence study in the UK | ||||
Mukesh Dhariwal, Christine Bouchet, Derek OBoyle, Javeed Khan, Alessandra Venerus, Anushini Muthutantri | ||||
Alcon, Novartis, IQVIA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study | |
Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK Real World Evidence study | ||||
Paul G. Ursell, Mukesh Dhariwal, Katarina Majirska, Frank Ender, Shoshannah Kalson-Ray, Alessandra Venerus, Cristiana Miglio & Christine Bouchet | ||||
Epsom & St Helier University Hospitals NHS Trust, Alcon Eye Care Limited, Novartis, IQVIA | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study | |
RISK FACTORS ASSOCIATED WITH PCO FOLLOWING CATARACT SURGERY: REAL-WORLD OUTCOMES STUDY IN THE UNITED KINGDOM (UK) | ||||
Dhariwal M, O’Boyle D, Bouchet C, Khan J, Venerus A, Muthutantri A | ||||
Alcon Eye Care Limited, Novartis, IQVIA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study | |
ASSOCIATION BETWEEN IOL DESIGN AND INCIDENCE OF PCO AND ND:YAG CAPSULOTOMY: A RETROSPECTIVE REAL WORLD EVIDENCE STUDY IN THE UK | ||||
Dhariwal M, O’Boyle D, Bouchet C, Khan J, Venerus A, Muthutantri A | ||||
Alcon Eye Care Limited, Novartis, IQVIA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Epidemiological study | ||
Chapter 4.1 Drug Utilisation and Prescription-Event Monitoring | ||||
Massoud Toussi and Deborah Layton | ||||
IQVIA, Cedex France; IQVIA, London | ||||
, Book chapter | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2018 | English | , Epidemiological study | |
#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study | ||||
Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck | ||||
Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden | ||||
, Poster | ||||
, England, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective cohort analysis | |
#4018 Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study | ||||
Simon Ekman,Maria Planck, Jens Benn Sørensen, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez-Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun | ||||
Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium, Department of Oncology, Radiumhospitalet, Oslo, Norway | ||||
, Poster | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective cohort analysis | ||
Feasibility Analysis and Data Visualization to Identify a Complex Group of Cancer in the Simulacrum | ||||
ALI ABBASI1,2, Shubham Tayal3, Deborah Layton1 and Toby Gosden1 | ||||
1IQVIA, LONDON, United Kingdom2University Medical Centre Groningen, Groningen, Netherlands3IQVIA, Gurgaon, India | ||||
, Poster | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Epidemiological study | |
Linking Electronic Health Data in Pharmacoepidemiology: Appropriateness and feasibility | ||||
Donna R. Rivera, PharmD. MSc. 1, Mugdha N. Gokhale, PhD., MS. 2, Matthew W. Reynolds, PhD3, Elizabeth B. Andrews, PhD., MPH 4, Danielle S. Chun 5, Kevin Haynes PharmD. MSc., PharmD., MSCE. 6, Michelle Jonsson Funk, PhD 5, Kristine E. Lynch 7, Jennifer L. Lund, PhD. 5, Helen Strongman, MSc. 8, Harshvinder Bhullar, MSc. 9 Sudha R. Raman, PhD 10 | ||||
National Cancer Institute, National Institutes of Health, Rockville, MD. 2 GlaxoSmithKline, Philadelphia, PA. 3 Evidera, Bethesda, MD. 4 RTI International, RTP, NC. 5 UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 6 Healthcore, Inc. Philadelphia, PA. 7 VINCI, Salt Lake City, UT. 8 London School of Hygiene and Tropical Medicine, London, UK 9 IQVIA, London, UK. 10 Department of Population Health Sciences, Duke University, Durham, NC. | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2018 | English | , Retrospective database analysis | |
A Data-driven Methodology to Define and visualise Line of Therapy for Real-World Data Epidemiology of Cancers. | ||||
ALI ABBASI1, Ruben Hermans1, Dony Patel1, Fiona Grimson1, Peter McMahon1, Joseph Kim1, Eric S Groves2 and Deborah Layton1. | ||||
1IQVIA, LONDON, United Kingdom, 2IQVIA, San Diego, CA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2018 | English | , Epidemiological study | |
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study. | ||||
Federici, M.O., McQuillan, J., Biricolti, G., Losi, S. | ||||
Eli Lilly Italy; IQVIA London | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Epidemiological study | |
Clinical Characteristics and Overall Survival of Patients Diagnosed With Non-Small Cell Lung Cancer (2006-2017) in Routine Clinical Practice: A Retrospective Analysis of a UK Hospital Database | ||||
Michael Snee, Sue Cheeseman, Matthew Thompson, Paul Godden, Will Sopwith, Carlos Chaib, Ariadna Juarez-Garcia, Laure Lacoin, John R Penrod, Geoff Hall | ||||
The Leeds Teaching Hospitals NHS Trust, Leeds, UK; IQVIA, London, UK; Bristol-Myers Squibb, Princeton, NJ, USA | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective database analysis | |
5-ASA prescription trends over time in inflammatory bowel disease 1996-2015 – a UK population-based study | ||||
Vipul Jairath (1,2), Suvi Hokkanen (3), Leonardo Guizzetti (2), Naomi Boxall (3), Sarah Campbell-Hill (4), Haridarshan Patel (4) | ||||
(1) Department of Medicine, Western University, London Ontario, Canada; (2) Robarts Clinical Trials Inc., London Ontario, Canada; (3) IQVIA, London, UK; (4) Takeda International – UK Branch, London, UK | ||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2018 | English | , Population Based Study | |
Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: Retrospective analysis of a UK trust database | ||||
Michael Snee, Sue Cheeseman, Matthew Thompson, Laure Lacoin, Will Sopwith, Paul Godden, Carlos Chaib, Melinda Daumont, John R. Penrod, John O’Donnell & Geoff Hall | ||||
The Leeds Teaching Hospitals NHS Trust, Leeds/United Kingdom; IQVIA, London/United Kingdom; Bristol-Myers Squibb, Braine L’Alleud/Belgium; Bristol-Myers Squibb, Madrid/Spain; Bristol-Myers Squibb, Princeton, New Jersey/United States of America | ||||
, Poster | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective database analysis | |
A Data-driven Methodology to Define and visualise Line of Therapy for Real-World Data Epidemiology of Cancers. | ||||
ALI ABBASI1, Ruben Hermans1, Dony Patel1, Fiona Grimson1, Peter McMahon1, Joseph Kim1, Eric S Groves2 and Deborah Layton1. | ||||
1IQVIA, LONDON, United Kingdom, 2IQVIA, San Diego, CA | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2018 | English | , Epidemiological study | |
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project | ||||
Rito Bergemann, James Allsopp, Harvey Jenner, Flora Ashley Daniels, Edmund Drage, Yevgeniy Samyshkin, Claude Schmitt, Steven Wood, David G. Kiely, Allan Lawrie | ||||
"1GlaxoSmithKline, Brentford, Middlesex, UK 2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK 3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK 4IQVIA, London, UK 5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK 7INSIGNEO, University of Sheffield, Sheffield, UK" | ||||
Pulm Circ. 2018 Oct-Dec;8(4):2045894018798613. doi: 10.1177/2045894018798613. |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease | 2018 | English | , Retrospective database analysis | |
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension | ||||
"David G. Kiely MD, Allan Lawrie, Orla Doyle PhD, Valentina Salvatelli PhD, Flora Ashley Daniels PhD, Edmund Drage, Harvey Jenner, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Rito Bergemann " | ||||
1Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK; 2Real-World & Analytical Solutions, IQVIA, London, UK; 3GSK, Brentford, Middlesex, UK; 4Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK; 5INSIGNEO, University of Sheffield, Sheffield, UK; 6Evalueserve UK Ltd, London, UK. 1 Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK. 2 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 3 INSIGNEO, University of Sheffield, Sheffield, UK. 4 Real-World & Analytical Solutions, IQVIA, London, UK. 5 GlaxoSmithKline, Brentford, Middlesex, UK. | ||||
European Respiratory Journal 2018 52: Suppl. 62, PA3082. |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease | 2018 | English | , Retrospective database analysis | |
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4. | ||||
1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain. | ||||
Infect Agent Cancer. 2018 May 2;13:15. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Infectious disease, Oncology | 2018 | English | , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research | |
Valoración de la innovación, ¿es “el innovómetro” una herramienta útil y su clasificación reproducible? | ||||
Otermin A, Callejo D, Gasche D, Viayna E, Rubio M, Sumalla M, Solozabal M. | ||||
HEOR-RWI, IQVIA | ||||
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2018 | Spanish | , Pricing & Reimbursement | |
Análisis coste-utilidad de antivirales de acción directa de segunda generación para la hepatitis C: Una revisión sistemática. | ||||
Puig-Junoy J123, Pascual-Argente N23, Puig-Codina L2, Planellas L4, Solozabal M4. | ||||
1Pompeu Fabra University (UPF), Department of Economics and Business; 2UPF Barcelona School of Management; 3Center for Research in Health and Economics (CRES-UPF); 4IQVIA, Real-World Insights, Barcelona | ||||
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2018 | Spanish | , Clinical setting: hospital, Literature Review, Review, Survey research | |
Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) | ||||
Martínez-Ginés ML, García-Domínguez JM, Forero L, Canal N, Rebollo P, Prefasi D, Honan CA, Maurino J. | ||||
Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, SpainDepartment of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain IQVIA, Barcelona, Spain Medical Department, Roche Farma, Madrid, Spain Department of Psychology, School of Medicine, University of Tasmania, Newnham, Australia | ||||
Mult Scler Relat Disord. 2018 May;22:115-119 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29656271 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2018 | English | , Burden of illness, Clinical setting: hospital, Patient questionnaire | |
Real World Data y Real World Evidence como fuentes de evidencia en oncología. Estado actual y perspectivas de futuro | ||||
Daniel Callejo y Anna de Prado | ||||
IQVIA Spain | ||||
New Medical Economics nº 79;22-24 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://issuu.com/raizpublicidad/docs/nme_num79/22 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | Spanish | , Clinical setting: hospital, Review | |
Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study | ||||
Johansson G, Mushnikov V, Bäckström T, Engström A, Khalid JM, Wall J, Hoti F | ||||
Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden | ||||
BMC Pulmonary Medicine (2018);18:17 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784707/ | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Burden of illness, clinical setting: Secondary care, Population Based Study, Retrospective database analysis | |
5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study | ||||
Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel | ||||
Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK, | ||||
Journal of Crohn, no. Supplement 1 (February): S309–10 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/p405-5-asa-prescription-trends-over-time-in-inflammatory-bowel-disease-1996-to-2015-x2013-a-uk-population-based-study.html | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Drug Utlization Study, Gastrointestinal disorders | 2018 | English | , Epidemiological study, Retrospective cohort analysis | |
5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study | ||||
Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel | ||||
Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK | ||||
Abstract: https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/p405-5-asa-prescription-trends-over-time-in-inflammatory-bowel-disease-1996-to-2015-x2013-a-uk-population-based-study.html | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder | ||||
Lähteenvuo M, Tanskanen A, Taipale H | ||||
Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland | ||||
JAMA Psychiatry (2018); 75(4):347-355 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2673379 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Prospective study | |
Real World Prescription Patterns of Beta-Blocker-Free Combination Treatment in the UK | ||||
Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch | ||||
13th EGS Congress, Florence, Italy - P4.034 |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: http://www.egs2018.org/sites/www.egs2018.org/files/documenti/egs2018-abstract-book.pdf | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Retrospective database analysis | |
US Multicenter Study of Time, Operational and Economic Efficiences Associated with Using a New Preloaded IOL Delivery System | ||||
Damien Goldberg, Katharine Coyle, Michael Jones, Stephen Lane, Terry Kim. Michael Keith | ||||
Damien Goldberg, Wolstan and Goldberg Eye Associates, Katharine Coyle, IQVIA | ||||
Conference |
||||
, Abstract | ||||
, USA | ||||
Abstract: plyvnas02heorCLIENT2017_Alcon Lens ObservationalAbstractAAOAlcon-AAO-pstr-2017.pdf | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Observational study | |
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China | ||||
Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu | ||||
IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai | ||||
Journal of Medical Economics |
||||
, Article | ||||
, China | ||||
Abstract: http://www.tandfonline.com/doi/abs/10.1080/13696998.2017.1417312 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2018 | English | , Cost effectiveness | |
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease | ||||
Huan Huang, Sharash Shetty, Elise Bauer, Kathleen Lang | ||||
Huan Huang, IQVIA | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/eprint/PqtzuUz9tjZ3mSt7AaIz/full | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
Investigating the secondary care system burden of influenza hospitalisation in clinical risk groups using the HES database | ||||
Skinner L, Clark-Wright J, Pedreño Fernandez D, Liu K, Carroll S , Minhas I | ||||
Sanofi Pasteur UK & Ireland, Maidenhead, UK; IQVIA, London, UK | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)34691-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2018 | English | , Burden of illness, Retrospective cohort analysis | |
A Retrospective Study of Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-cancer Controls in the US. | ||||
Near A, Iqbal S, Huang H, Dhopeshwarkar N, Lang K, Wallis N. | ||||
ASH 59th Annual Meeting and Exposition |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries | ||||
Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
Prentice M1, Mpima S2, Martinez S2, Nasuti P2, Davda R1, Payne H1 | ||||
1 University College Hospital, London, UK, 2 IQVIA , London, UK | ||||
, Asia Pacific, Europe | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Trends in Incidence of ACL Reconstruction and Concomitant Procedures Among Commercially Insured Individuals in the United States, 2002-2014. | ||||
Herzog MM, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT | ||||
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; University of North Carolina Injury Prevention Research Center; Injury Surveillance and Analytics, IQVIA | ||||
Sports Health. 2018 Nov/Dec;10(6):523-531 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/30355175 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2018 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Treatment Pathways of Primary Open Angle Glaucoma Prior to Laser Surgery: Real World Evidence from UK Ophthalmology Clinics | ||||
Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch | ||||
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6109 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://iovs.arvojournals.org/article.aspx?articleid=2693261&resultClick=1 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | ||
Fundamentals of Sports Analytics | ||||
Wasserman EB, Herzog MM, Collins CL, Morris SN, Marshall SW | ||||
Datalys Center for Sports Injury Research and Prevention, Inc.; Department of Epidemiology, University of North Carolina at Chapel Hill; Real-World Evidence, IQVIA; University of North Carolina Injury Prevention Research Center | ||||
Clin Sports Med. 2018 Jul;37(3):387-400 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/29903381 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2018 | English | , Epidemiological study, Literature Review, Review | |
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
A Second Look at NBA Game Schedules: Response to Teramoto et al. | ||||
Mack CD, Herzog MM, DiFiori JP, Meisel PL, Dreyer NA | ||||
QuintilesIMS Real-World Insights, Research Triangle Park, USA. Electronic address: christina.mack@quintilesims.com. QuintilesIMS Real-World Insights, Research Triangle Park, USA. National Basketball Association, USA; Division of Sports Medicine and Non-Operative Orthopaedics, University of California Los Angeles, USA. National Basketball Association, USA. QuintilesIMS Real-World Insights, Cambridge, USA. | ||||
J Sci Med Sport. 2018 Mar;21(3):228-229 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28823474 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Methodology | 2018 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension. | ||||
Kiely D., Lawrie A., Doyle O., Salvatelli V., Ashley Daniels F., Drage E., Jenner H., Rigg J, Schmitt C., Samyshkin Y., Bergemann R. | ||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2018 | English | , Predictive analytics | |
Benzodiazepine prescribing in the elderly in Germany and Korea: A comparison of two observational studies . | ||||
Woodcock BG, Kostev K, Shin JY | ||||
Int J Clin Pharmacol Ther. 2017 May 10. doi: 10.5414/CP203042. [Epub ahead of print] |
||||
, Article | ||||
, Germany, Korea | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Observational study | |
Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany – a retrospective analysis of real-world data | ||||
Dombrowski S, Kostev K, Jacob L | ||||
Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051-y. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Real World Data, Retrospective cohort analysis | |
Utilizing Real World Data to Understand Impact of Patient Support Programs on Adherence and Outcomes: A Case Study. | ||||
Jaganathan S, Burudpakdee C, von Allmen H. | ||||
PMSA |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Oral contraceptive use and fracture risk - a retrospective study of 12,970 women in the UK | ||||
Dombrowski S, Jacob L, Hadji P, Kostev K | ||||
Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036-x. [Epub ahead of print] |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Womens Health | 2017 | English | , Retrospective cohort analysis | |
Real-world effectiveness of antipsychotic treatments among patients with schizophrenia and affective symptoms | ||||
Tiihonen J, Lähteenvuo M, Hoti F, Vattulainen P, Taipale H, Tanskanen A | ||||
Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden | ||||
European Psychiatry (2017) 41 (Supplement): S386 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0924933817326986 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Seasonality of insulin use in German outpatients with diabetes: a retrospective analysis | ||||
Kostev K, Gläser S, Jacob L | ||||
J Diabetes Sci Technol. 2017 Apr 1:1932296817703994. doi: 10.1177/1932296817703994. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective cohort analysis | |
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients | ||||
Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 | ||||
1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-cra-2017.pdf | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2017 | English | , Database Study | |
Patterns of benzodiazepine prescribing by neuropsychiatrists and general practitioners for elderly patients in Germany in 2014 | ||||
Mell T, Jacob L, Fuhr I, Dick S, Rapp MA, Kostev K | ||||
Int J Clin Pharmacol Ther. 2017 Apr 13. doi: 10.5414/CP202904. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | ||
Evaluating Renal Cell Carcinoma treatment options using real world data: findings from an oncology survey across seven countries | ||||
S. Mpima, S. Menon, P. Nasuti, H. Mistry | ||||
IQVIA London UK | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Asia Pacific, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
Impact of adalimumab’s patient support program on clinical outcomes in inflammatory bowel diseases: Results from the COMPANION study | ||||
Marshall JK1, Narula N1, Millson B2, Charland K2, Sung M2, Gaetano T3, McHugh K3, Latour M3, Laliberté MC3 | ||||
European Crohn’s and Colitis Organization 2017 Conference, February 15-18, Barcelona, Spain |
||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2017 | English | , Retrospective database analysis | |
Depression risk in patients with rheumatoid arthritis in the United Kingdom | ||||
Jacob L,Rockel T, Kostev K | ||||
Rheumatol Ther. 2017 Mar 20. doi: 10.1007/s40744-017-0058-2. [Epub ahead of print] |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Rheumatology | 2017 | English | ||
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions | ||||
Catherine Collet(1) – Anne de Saunière (1) – Dominique Perrot (2) – Isabelle Bardoulat (2) | ||||
(1) ARS Ile de France, Paris, France – (2) Quintiles IMS, Paris, France | ||||
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Real World analysis for immune related side effects in 3000 patients | ||||
Mitrofan L 1, Moehler T 2, Ruiz M 3 | ||||
1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Europe, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
Prevalence of Primary Biliary Cholangitis in Canada: First National Study | ||||
Yoshida EM1, Thiele S2, Fischer A2, Mason A3, Shah H4, Peltekian K5, Hux M2, Borrelli R2 | ||||
1 Division of Gastroenterology, University of British Columbia 2 QuintilesIMS 3 University of Alberta 4 University of Toronto 5 Dalhousie University | ||||
CANADIAN DIGESTIVE DISEASES 2017 CONFERENCE, MARCH 3-6, BANFF, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/cddw-conference.pdf | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2017 | English | , Retrospective cohort analysis | |
Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany. | ||||
Bohlken J, Jacob L, Kostev K | ||||
J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , Retrospective cohort analysis | |
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia | ||||
Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
JAMA Psychiatry. (2017) 74(7):686-693 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2629295 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Prospective study | |
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients: Three-Year Results from the COMPANION Study in Gastroenterology Patients | ||||
Marshall JK1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 | ||||
1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
Canadian Digestive Diseases Week 2017 Annual Scientific Conference, March 3-6, Banff, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/cddw-abbvie.pdf | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2017 | English | , Database Study | |
Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany | ||||
Jacob L, Spiess A, Kostev K | ||||
Ger Med Sci. 2017 Feb 9;15:Doc04. doi: 10.3205/000245. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Ophthalmology | 2017 | English | , Epidemiological study | |
LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
"M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi" | ||||
EMIF group | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Estimating glomerular filtration rate in primary care electronic medical record databases in Europe | ||||
Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2 | ||||
1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands | ||||
22nd ISPOR Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Methodology, Nephrology | 2017 | English | , Clinical setting: Primary care, Retrospective database analysis | |
The impact of physician-level drug budgets on prescribing behaviour | ||||
Fischer KE; Koch T; Kostev K; Stargardt T | ||||
Eur J Health Econ. 2017 Feb 13. doi: 10.1007/s10198-017-0875-9. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Health policy | 2017 | English | ||
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study | ||||
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
The Lancet Psychiatry (2017) 4(7):547-553 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2215036617301347?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective database analysis | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. | ||||
Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom. | ||||
Breast. 2017 Apr;32:247-255. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , clinical setting: Secondary care, Retrospective database analysis | |
Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders -A retrospective analysis of subsequent pregnancy outcomes- | ||||
Jacob L, Kalder M, Arabin B, Kostev K | ||||
J Cancer Res Clin Oncol. 2017 Feb 20. doi: 10.1007/s00432-017-2352-3. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Surgery, Womens Health | 2017 | English | , Retrospective cohort analysis | |
LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
"M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi" | ||||
EMIF group | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Association of Dipeptidyl Peptidase 4 Inhibitors with Risk of Metastases in Patients with Type 2 Diabetes and Breast, Prostate or Digestive System Cancer | ||||
Rathmann W, Kostev K | ||||
J Diabetes Complications. 2017 Jan 26. pii: S1056-8727(16)31034-0. doi: 10.1016/j.jdiacomp.2017.01.012. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2017 | English | ||
LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
"M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi" | ||||
EMIF group | ||||
Journal of Hepatology ; Volume 66, Issue 1, Supplement |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
Compliance with vaccination against tick-borne encephalitis virus in Germany | ||||
Jacob L, Kostev K | ||||
Clin Microbiol Infect. 2017 Jan 28. pii: S1198-743X(17)30045-9. doi: 10.1016/j.cmi.2017.01.012. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | ||
Characteristics of Patients with Heart Failure Prescribed Sacubitril/Valsartan in the Primary Care Setting in Germany | ||||
Klebs S, Balas B, Grunow SS, Schindler M,Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Wirta SB | ||||
ESC Meeting 2017 |
||||
, Conference | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | ||
Characteristics of Patients with Heart Failure Prescribed Sacubitril/Valsartan in the Primary Care and Cardiology Settings in Germany | ||||
Wirta SB, Klebs S, Grunow SS, Schindler M,Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B | ||||
ESC Meeting 2017 |
||||
, Conference | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | ||
EXTRAPOLATION OF ADULT DATA FOR PEDIATRIC DRUG BENEFIT ASSESSMENT IN THE AMNOG DOSSIER IN THE LIGHT OF THE NEW AMVSG | ||||
Stoecker P, Hofmann-Xu L, Bonduelle D | ||||
QuintilesIMS Health Germany, Munich, Germany | ||||
ISPOR Glasgow 2017 |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Pediatrics | 2017 | English | , Retrospective database analysis | |
Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model. | ||||
Gerlier L1, Lamotte M1, Grenèche S2, Lenne X3, Carrat F4,5, Weil-Olivier C6, et al. | ||||
1 QuintilesIMS, Zaventem, Belgium 2 AstraZeneca, Rueil-Malmaison, France 3 University Lille Nord de France, Lille, France 4 Sorbonne Universités, Paris, France 5 Saint-Antoine Hospital, Paris, France 6 University Paris VII, Paris, France | ||||
Appl Health Econ Health Policy, 2017, Apr, 15(2): 261-276 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27943165 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2017 | English | ||
DIFFERENCES AND DECISION DRIVERS IN THE HTA-OUTCOME CATEGORY LOWER BENEFIT BETWEEN IQWIG AND G-BA ASSESSMENT IN THE GERMAN AMNOG PROCESS | ||||
von Hein, Mirko; Peters, Ann-Sophie; Jakovac, Mihael | ||||
QuintilesIMS | ||||
ISPOR 20th Annual European Congress |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2017 | English | , Public Health | |
IMPLICATIONS OF THE GERMAN HTA-PROCESS ON MARKET-UPTAKE OF ORAL TREATMENTS FOR TYPE-2-DIABETES (T2DM) SINCE 2007 | ||||
Dr. Roger-Axel Greiner; Tina Fischer; Benno Antoni; Dr. Ariane Batscheider | ||||
ISPOR 20th Annual European Congress |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Market impact, Retrospective database analysis | |
CLOSING THE EVIDENCE GAP FOR ORPHAN DRUGS: DO GERMAN REGULATORY REQUIREMENTS GIVE INCENTIVES FOR HIGH LEVEL EVIDENCE GENERATION? | ||||
Ana Babac, Roger-Axel Greiner, Doreen Bonduelle | ||||
"QuintilesIMS, IMS Health GmbH & Co. OHG, Landshuter Allee 10, 80637 München " | ||||
ISPOR 20th Annual European Congress, Glasgow |
||||
, Poster | ||||
, Germany | ||||
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PHS | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2017 | English | , Pricing & Reimbursement, Retrospective database analysis | |
Drug Treatment Patterns in Patients Newly Diagnosed with Heart Failure: A Retrospective Population-Based Cohort Study in Sweden | ||||
Wikström G, Lindmark K, Olofsson M, Stålhammar J, Jonasdottir Bergman G, Johansson S, Wintzell V., Bruce Wirta S, Balas B, Boman K | ||||
Uppsala University, Institute for Medical Sciences - Uppsala - Sweden||IMS Health Sweden, Stockholm, Sweden | ||||
European Journal of Heart Failure ( 2017 ) 19 ( Suppl. S1 ), 55 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://esc365.escardio.org/Congress/Heart-Failure-2017-4th-World-Congress-on-Acute-Heart-Failure/Poster-Session-1-Chronic-heart-failure/152433-drug-treatment-patterns-in-patients-newly-diagnosed-with-heart-failure-a-retrospective-population-based-cohort-study-in-sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
CONVERSION OF A FRENCH ELECTRONIC MEDICAL RECORD (EMR) DATABASE INTO THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL. | ||||
Schwalm MS 1, Raoul T 1 ,Chu D 2 , Shah U 3, Potdar M 4, Van Zandt M 5,Coffin G 1, Jouaville SL1 | ||||
1 QuintilesIMS, 90-92 Route de la Reine 92773 Boulogne-Billancourt, France 2 QuintilesIMS, One IMS Drive Plymouth Meeting, PA 19462 USA 3 QuintilesIMS, 100 IMS Drive Parsippany, NJ 07054 USA 4 QuintilesIMS, 291 King George Road, Warren, NJ 07059Warren, NJ USA 5 QuintilesIMS, 425 Market, San Francisco, CA 94105 San Francisco, CA USA | ||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology | 2017 | English | , Clinical setting: Primary care, Methodology | |
Prevalence, characteristics and management of asthma patients with frequent exacerbations ? an observational study in Sweden (PACEHR). | ||||
Janson C1, Lisspers K2, Ställberg B2, Johansson G3, Thuresson M4, Telg G4, Larsson K5. | ||||
1 Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 2 Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 4 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 5 Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm | ||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | ||
Prevalence, characteristics and management of asthma patients with frequent exacerbations – an observational study in Sweden (PACEHR). | ||||
Janson C1, Lisspers K2, Ställberg B2, Johansson G3, Thuresson M4, Telg G4, Larsson K5. | ||||
1 Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 2 Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 4 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 5 Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Comparison of cost-effectiveness acceptability curves (CEAC) in modeled analyses with and without established heterogeneity of patient characteristics. | ||||
Foos V, McEwan P, Lamotte M | ||||
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Cost effectiveness | |
Features of severe asthma in primary care – an observational study (PACEHR). | ||||
Larsson K1, Ställberg B2, Lisspers K2, Telg G3, Johansson G4, Thuresson M3, Janson C5. | ||||
1 Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm 2 Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 3 Faculty of Medicine, University of Iceland, Reykjavik, Iceland 4 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden 5 Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden | ||||
ERS International Congress, Milan, Italy, September 9-13 2017 |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | ||
A COST-EFFECTIVENESS ANALYSIS COMPARING THE ORIGINATOR RECOMBINANT HUMAN ALFA TO THEIR BIOSIMILARS FOLLITROPIN ALFA FOR THE TREATMENT OF INFERTILITY. | ||||
Ravonimbola H(1), Petrica N (1), Maurel F(1), Murphy C(2), Doré C(2), Fresneau L(2), | ||||
(1) QuintilesIMS, Paris France (2) Merck Serono, France | ||||
ISPOR 2017 |
||||
, Poster | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(17)31033-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2017 | English | , Cost effectiveness, Literature Review, Randomised controlled trial | |
Assessing the economic burden of type 2 diabetes in China reflecting the current standard of the disease management and for improved management scenarios using a modeling approach. | ||||
Foos V1, Lamotte M1, McEwan P4, Jiang X3, Zhang YL3, Qu S2, De Moor R1, Ramos R1, Xiong T2, Wang K3 | ||||
1 IMS Health, Brussels, Belgium 2 IMS Health, Shanghai, China 3 Eli Lilly, Shanghai, China 4 Swansea University, Wales | ||||
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
||||
, Abstract | ||||
, China | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Cost effectiveness | |
Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment | ||||
Rockberg J, Jörgensen L, Taylor B, Sobocki P, Johansson G | ||||
QuintilesIMS, Solna, Sweden | ||||
Preventive Medicine Reports, (2017) vol 6, 203-206 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2211335517300438?via%3Dihub#! | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Approaches to standardizing cardiovascular risk equation endpoints in order to facilitate their inclusion within a type 2 diabetes model. | ||||
McEwan P, Foos V, Lamotte M | ||||
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Cost effectiveness | |
Economic burden of COPD in a Swedish cohort: the ARCTIC study | ||||
Lisspers K, Larsson K, Johansson G, Janson C, Costa-Scharplatz M, Gruenberger JB, Uhde M, Jorgensen L, Gutzwiller FS, Ställberg B | ||||
Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala|IQVIA, Stockholm, Sweden|IQVIA, Copenhagen, Denmark | ||||
Int J COPD (2018) 2018:13, 275-285 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.dovepress.com/economic-burden-of-copd-in-a-swedish-cohort-the-arctic-study-peer-reviewed-article-COPD | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Cost of illness, Retrospective cohort analysis | |
THE IMPACT OF RESPIRATORY DEPRESSION FOLLOWING PLANNED INPATIENT SURGERIES ON HOSPITAL RESOURCE UTILIZATION AND CHARGES ACROSS THE UNITED STATES | ||||
Ben-Joseph R1, Gordon RJ2, Chingcuanco F1, Zhao S1, Ni W1, Divino V3, DeKoven M3, Meier A2 | ||||
1Millennium Health, San Diego, CA, USA, 2University of California at San Diego, La Jolla, CA, USA, 3QuintilesIMS, Fairfax, VA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine, Surgery | 2017 | English | , Retrospective database analysis | |
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
JHEOR 2017;5(1):89-108 |
||||
, Article | ||||
, Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
THE TREATMENT OF PATIENTS WITH INJECTABLE OPIOIDS FOR UNCONTROLLED POSTOPERATIVE PAIN IN THE INPATIENT SETTING: INCIDENCE AND IMPACT ON HOSPITAL CHARGES | ||||
Chingcuanco F1, Divino V2, DeKoven M2, Gordon RJ3, Meier A3, Ben-Joseph R1 | ||||
1Millennium Health, San Diego, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3University of California at San Diego, La Jolla, CA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine, Pain | 2017 | English | , Retrospective database analysis | |
THE ECONOMIC IMPACT OF DELAYING BRAIN METASTASES IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE COMMERCIALLY INSURED US POPULATION | ||||
Wong W1, Burudpakdee C2, Seetasith A2, Corvino F3, Yeh D1, Gubens M4 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3Genesis Research, Hoboken, NJ, USA, 4University of California, San Francisco, San Francisco, CA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
Brexpiprazole use in long-term care patients with major depressive disorder: Results from a retrospective analysis of long-term care data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4University of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling. | ||||
Ramos M1, McEwan P2, Lamotte M1, Foos V1 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Nov 4 - 8, 2017, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Methodology | 2017 | English | , Cost effectiveness | |
Adherence and treatment patterns of early adopters of brexpiprazole therapy with schizophrenia – Results from a retrospective analysis of longitudinal prescription data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Patient adherence to subcutaneous IFN beta-1a injections using the Rebismart® injection device:a retrospective real-world among Dutch and German patients with multiple sclerosis. | ||||
Krol M1, deVoer G2, Osowski U3 | ||||
1 QuintilesIMS, The Netherlands 2 Merck B.V., Schiphol-Rijk, the Netherlands 3 Merck KGaA, Darmstadt, Germany | ||||
, Article | ||||
, Germany, Netherlands | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513881/ | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , clinical setting: Secondary care, Compliance, Retrospective database analysis | |
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS | ||||
Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F* | ||||
IQVIA France - RWI | ||||
ISPOR 2017 |
||||
, Poster | ||||
, Australia, Canada, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2017 | English | , Cost effectiveness, Literature Review, Pricing & Reimbursement, Review | |
Adherence and treatment patterns in brexpiprazole therapy in long-term care patients with schizophrenia: Results from a retrospective analysis of long-term care data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4University of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany | ||||
Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5 | ||||
1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany | ||||
, Poster | ||||
, Germany | ||||
Abstract: https://academic.oup.com/annonc/article/28/suppl_2/mdx091.052/3799717/132PReal-world-treatment-patterns-and-outcomes-for | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health status & patient reported outcomes, Oncology | 2017 | English | , clinical setting: Secondary care, Patient questionnaire, Quality of life | |
Gender and economic aspects of COPD in a Swedish cohort: The ARCTIC study | ||||
Lisspers K, Larsson K, Jansson C, Ställberg B, Gutzwiller F S, Mezzi K, Udhe M, Jorgensen L, Johansson G | ||||
Uppsala University, Uppsala, Sweden|IQVIA, Stockholm, Sweden|IQVIA, Copenhagen, Denmark | ||||
European Journal of Respiratory Research (2017) 50: PA932 |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/50/suppl_61/PA932 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Clinical setting: Primary care, Cost of illness, Epidemiological study, Observational study | |
Brexpiprazole use in patients with major depressive disorder: Results from a retrospective analysis of longitudinal prescription data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Exploration of run-time requirements in probabilistic sensitivity analysis utilizing a patient level based type 2 diabetes simulation model. | ||||
Foos V1, Lamotte M1, Sathananthan A2, Altrabsheh E2, McEwan P3 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2017 | English | , Cost effectiveness | |
Extent and Impact of Late Versus Early COPD Diagnosis in Women in the Swedish ARCTIC Study | ||||
Lisspers K, Larsson K, Jansson C, Ställberg B, Gutzwiller F S, Mezzi K, Udhe M, Jorgensen L, Johansson G | ||||
Uppsala University, Uppsala, Sweden|IQVIA, Stockholm, Sweden|IQVIA, Copenhagen, Denmark | ||||
ATS 2017 |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4705 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Clinical setting: Primary care, Cost analysis, Epidemiological study, Observational study | |
Impact of A Pharmacist Medication Adherence Consultation Program on Health Care Costs and Risk of Hospitalization | ||||
Wade R.L.1, Hill J.W.1, Akinbosoye O.2, Jiang Z.2, Mu Y.2, Sun K.1, Karkare S3, Taitel M.S.2 | ||||
1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health,Deerfield, IL, USA | ||||
VALUE IN HEALTH. 2015. 18(3):A3 |
||||
, Podium presentation | ||||
, USA | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(15)00074-1/pdf | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2017 | English | , Retrospective database analysis, Survey research | |
Determinants of the relationship between improved glucose control and modelled health outcomes in type 2 diabetes simulation models. | ||||
Foos V1, Lamotte M1, Altrabsheh E2, Sathananthan A2, McEwan P3 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, November 4 - 8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2017 | English | , Cost effectiveness | |
Characteristics of asthma patients with frequent exacerbations ? an observational study in Sweden | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K | ||||
Uppsala University, Uppsala, Sweden | ||||
European Journal of Respiratory Research (2017) 50: PA3870 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/50/suppl_61/PA3870 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
The cost-effectiveness of IVF treatments Gonal-f® versus HP-hMG in the United Arab Emirates (UAE). | ||||
Mohamed E1, Garg N, Madkour W, Zaheer H, Sayed W, Noah B, Fakih A, Farag T, Wadie G, Jain R, Prasanna R, van Gils C2 | ||||
1 Dubai gynaecology & fertility center , UAE 2 Real-World Evidence Solutions QuintilesIMS, Belgium | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Abstract | ||||
, UAE | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2017 | English | , clinical setting: Secondary care, Cost effectiveness | |
Features of severe asthma in primary care – an observational study | ||||
Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C | ||||
Department of Environmental Medicine, Karolinska Institutet, Solna, Sweden | ||||
European Journal of Respiratory Research (2017) 50: PA1601 |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/50/suppl_61/PA1601 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib. | ||||
Chen CC1, Parikh K2, Abouzaid S2, Purnomo L2, McGuiness C1B, Hussein M2, Wade RL1 | ||||
1QuintilesIMS, Plymouth Meeting, Pennsylvania. 2Celgene, Summit, New Jersey | ||||
J Manag Care Spec Pharm. 2017 Feb;23(2):236-246 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2017.23.2.236 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) | ||||
Martínez-Ginés ML, García-Domínguez JM, Sarmiento M, Maurino J | ||||
Martínez-Ginés ML: Servicio de Neurología, Hospital Universitario Gregorio Marañón, Madrid, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
Neurología 2017; Apr 5 [Epub ahead of print] |
||||
, Letter | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-adaptacion-cultural-al-espanol-del-S0213485317301056 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Neurological disorders | 2017 | Spanish | , Patient questionnaire | |
L’observance médicamenteuse des patients diabétiques de type 2 en île-de-france : état des lieux et priorités d’actions [Drug adherence in patients with type 2 diabetes in Île-de-France: state of play and priorities for action]. | ||||
Bardoulat I1, Chauvin F1, De Saunière A2, Le Jeunne P1, Perrot D1, Collet C2 | ||||
1 QuintilesIMS, La Défense, France 2 ARS Île-de-France, Paris, France | ||||
9ème Colloque données de santé en vie réelle / AFCROs (Cité Universitaire, Paris, 13 juin 2017) |
||||
, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Impact of locally advanced or metastatic prostate cancer on the quality of life | ||||
López-Calderero I, López-Fando L, Ríos-González E, Maisonobe P, Hernández-Yuste E, Sarmiento-Jordán M | ||||
López-Calderero I: Hospital Can Misses, Ibiza, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
Actas Urológicas Españolas 2017;41(6):368-75 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28256271 | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Urology | 2017 | English | , Quality of life | |
Evaluation of the effectiveness of risk minimisation measures: a survey among health care professionals to assess their knowledge and attitudes on prescribing conditions of Instanyl® in France and the Netherlands. | ||||
Toussi M1, Garofano A1, Jouaville L1, Bardoulat I1, Mitrofan L1 | ||||
1 QuintilesIMS, La Défense, France | ||||
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2017, August 26-30, Montreal, Canada |
||||
, Poster | ||||
, France, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Pain, Risk Management & REMS | 2017 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Public Health, Survey research | |
Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment | ||||
Rockberg J1, Jørgensen L1, Taylor B2, Sobocki P1, Johansson G3. | ||||
1 QuintilesIMS, Solna, Sweden. 2 Amgen Inc, Thousand Oaks, CA, USA. 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. | ||||
Prev Med Rep |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374870/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Real World Evidence | |
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions [Drug adherence in patients with type II diabetes in the Île-de-France region: study results and priorities for action]. | ||||
Collet C1, De Saunière A1, Perrot D2, Bardoulat I2 | ||||
1 ARS Ile de France, Paris, France 2 Quintiles IMS, Paris, France | ||||
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Trends in the Diagnosis of Vitamin D Deficiency | ||||
Emre Basatemur, MBBS, MRCPCH, a Laura Horsfall, PhD, b Louise Marston, PhD, b Greta Rait, MD, b Alastair Sutcliffe, PhDa | ||||
University College London | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
Long-term impact of grass-pollen (GP) sublingual immunotherapy tablet (SLIT) on allergic rhinitis (AR) and on allergic asthma (AA) onset and progression. | ||||
Devillier P1, Molimard M2, Demoly P3, Ansolabehere X4, Bardoulat I4, Coulombel N4, Maurel F4, Le Jeunne P4 | ||||
1 UPRES EA 220, Department of Airway Diseases, Hospital Foch, University Versailles Saint Quentin, Suresnes, France 2 Pharmacology Department, CHU of Bordeaux-University, INSERM CR1219 unit, Bordeaux, France 3 Departement of Pneumology and Addictology, Arnaud de Villeneuve Hospital- CHRU of Montpellier, Montpellier, France 4 QuintilesIMS, Real-World Insights (RWI) Department, La-Défense, France. | ||||
ISPOR 20th Annual European Congress, 2017, 4-8 November, Glasgow, Scotland |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Otolaryngology, Respiratory disease | 2017 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK | ||||
Nicola Adderley, Ronan Ryan and Tom Marshall | ||||
University of Birmingham | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Retrospective database analysis | |
Extent and impact of late vs early stage COPD diagnosis in a Swedish cohort: The ARCTIC study. | ||||
Larsson K, Janson C, Ställberg B, Lisspers K, Olsson P, Kostikas K, Uhde M, Jorgensen L, Gutzwiller F S, Johansson G. | ||||
Nordic Lung Congress 2017, 10-12 May Visby Sweden |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Real World Evidence | |
Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study. | ||||
Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger J-B, Gutzwiller F S, Jorgensen L, Uhde M, Lisspers K. | ||||
Nordic Lung Congress 2017, 10-12 May, Visby Sweden |
||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Real World Evidence | |
"Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource" | ||||
"Gayan Perera, Lars Pedersen, David Ansel, Myriam Alexander, H. Michael Arrighi, Paul Avillach, Nadia Foskett, Rosa Gini, Mark F. Gordon, Usha Gungabissoona, Miguel-Angel Mayer, Gerald Novak, Peter Rijnbeek, Gianluca Trifiro, Johan van der Lei, Pieter J. Visser, Robert Stewart." | ||||
The European Medical Information Framework | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Statin initiations and QRISK2 scoring in UK general practice: a THIN database study | ||||
Samuel Finnikin, Ronan Ryan and Tom Marshall | ||||
Birmingham university | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Retrospective database analysis | |
A Budget Impact Model of Third-Line or Later Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer. | ||||
Ferrufino C, Wiseman F, Wert TD, Barghout V | ||||
QuintilesIMS Health, Falls Church, VA; Taiho Oncology, Priceton, NJ; Taiho Oncology, Inc, Princeton, NJ; VEB Healthcare, Morristown, NJ | ||||
ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact | |
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4 | ||||
1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | English | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research | |
"Seasonality of urinary tract infections in the United Kingdom in different age groups: longitudinal analysis of The Health Improvement Network (THIN)" | ||||
"A. ROSELLO, K. B. POUWELS, M. DOMENECH DE CELLÈS, E. VAN KLEEF, A. C. HAYWARD, S. HOPKINS, J. V. ROBOTHAM, T. SMIESZEK, L. OPATOWSKI AND S. R. DEENY" | ||||
PHE | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2017 | English | , Retrospective database analysis | |
Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery | ||||
Mendicute J1, Pablo L2, Vélasque L3, Martinez A4, Asmar J5, Schweitzer C6 | ||||
1.Hospital Universitario Donostia Servicio de Oftalmología 2.Hospital Universitario Miguel Servet Servicio de Oftalmología 3.Centre Retine Gallien Bordeaux 4.Alcon Laboratories, Inc., Fort Worth, TX 5.IMS Health Information Solutions France 6.Department of Ophthalmology, Bordeaux University Hospital, France | ||||
ASCRS (cataract congress) |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Cost effectiveness, Observational study, Prospective study | |
Análisis de coste-efectividad de empagliflozina en pacientes con diabetes mellitus tipo 2 y enfermedad cardiovascular establecida en España [Analysis of cost-effectiveness of empagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease established in Spain]. | ||||
Barrull C1, Massafrets M2, Planellas L1, Perulero N1 | ||||
1 RWI, QuintilesIMS, Barcelona 2 Market Access Department, Boehringer Ingelheim, Barcelona | ||||
XXXVII Jornadas de Economía de la Salud2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes, Health economics, Pricing and reimbursement | 2017 | Spanish | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Cost effectiveness, Cost utility, Literature Review, Patient questionnaire, Randomised controlled trial | |
"Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a largescale multinational family of cohort studies of five outcomes" | ||||
"Vincent Lo Re, Dena M Carbonari, M Elle Saine, Craig W Newcomb, Jason A Roy, Qing Liu, Qufei Wu, Serena Cardillo, Kevin Haynes, Stephen E Kimmel, Peter P Reese, David J Margolis, Andrea J Apter, K Rajender Reddy, Sean Hennessy, Harshvinder Bhullar, Arlene M Gallagher, Daina B Esposito, Brian L Strom." | ||||
University of Pennsylvania | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Etude DISCOVER France - étude enrichie visant à décrire la prise en charge des patients diabétiques de type 2 | ||||
Harmand S.1, Maillard C.1, Thomas F.2 | ||||
1. QuintilesIMS, La Défense, France. 2. Astra Zeneca, La Défense, France | ||||
ADELF-SFSP congress (l'Association des épidémiologistes de langue française - Société française de santé publique) June 2017 in France |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | French | , Clinical setting: Primary care, Longitudinal study, Observational study, Patient questionnaire, Quality of life, Real World Data | |
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine]. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4 | ||||
1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research | |
Incidence, treatment and recurrence of endometriosis in a UK-based population analysis using data from The Health Improvement Network and the Hospital Episode Statistics database | ||||
Lucia Cea Soriano, Esther López-Garcia , Renate Schulze-Rath & Luis A. Garcia Rodríguez | ||||
CEIFE, Bayer | ||||
, In press/to be published | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2017 | English | , Retrospective database analysis | |
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe. | ||||
Katz P1, Pegoraro V2, Liedgens H1. | ||||
1 Grunenthal GmbH , Aachen , Germany. 2 QuintilesIMS, Milan, Italy. | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28537441 | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2017 | English | , Database Study, Epidemiological study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
Vacunas. 2017;18(2):36-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Análisis de las diferencias en el tiempo de elaboración de los informes de posicionamiento terapéutico [Analysis of the differences in the time of elaboration of the reports of therapeutic positioning]. | ||||
Viayna E, Planellas L, Solozabal M | ||||
Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Literature Review, Public Health | |
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults | ||||
Strandberg AY, Khanfir H, Mäkimattila S, Saukkonen T, Strandberg TE, Hoti F | ||||
University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland | ||||
Ann Med. (2017) 49(4):357-364 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/07853890.2016.1278302?journalCode=iann20 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Comparison of incremental cost-utility ratios and sales of direct oral anticoagulants across EU-5 countries. | ||||
Viayna E, Planellas L | ||||
Quintiles IMS | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Cost utility, Literature Review | |
Revisión de modelos económicos de coste-efectividad/ coste-utilidad desarrollados con los nuevos agentes antivirales de acción directa para el tratamiento de pacientes con hepatitis c [Review of economic cost-effectiveness / cost-utility models developed with new direct-acting antiviral agents for the treatment of patients with hepatitis C]. | ||||
Planellas L1, Pascual N2, Solozabal M1, Rebollo P1, Puig-Junoy J2 | ||||
1 QuintilesIMS, RWI, Barcelona, Spain 2 CRES - Universitat Pompeu Fabra, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/#comunicaciones | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2017 | Spanish | , Cost effectiveness, Literature Review, Review | |
Modelización del comportamiento de fármacos biosimilares en 5 países de europa [Modeling of the behavior of biosimilar drugs in 5 European countries]. | ||||
Manganelli AG1, Solozabal M2, Planellas L2, Rebollo P2, Puig-Junoy J1 | ||||
1 CRES - Universitat Pompeu Fabra, Barcelona, Spain 2 QuintilesIMS, RWI, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.aes.es/jornadas/es/#comunicaciones | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Drug Utlization Study | 2017 | Spanish | , Clinical setting: hospital | |
Tiempos de Acceso Regional de Productos Hospitalarios [Regional Access Times for Hospital Products]. | ||||
Solozabal M1, Fraile S2, Gómez V1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis | |
Relación entre los tiempos del proceso de P&F y el acceso regional de productos hospitalarios en España [Relationship between the times of the P & F process and the regional access of hospital products in Spain]. | ||||
Gómez V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Evolution of the time-to-market of hospital products in Spain. | ||||
Gómez-Navarro V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | English | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey | ||||
Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Cecere FL9, Lunghi A9, Del Conte A10, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG11, Gianetta M11, Pacchiana MV11, Pegoraro V12, Cataldo N12, Bria E13, Novello S11. | ||||
1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 2 Clinical Cancer Center "Giovanni Paolo II", Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology, SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Rome, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Department of Medical Oncology, Azienda per l'Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy 11 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 12 IQVIA, RWI, Milan, Italy 13 Medical Oncology, Department of Medicine, Verona, Italy | ||||
Support Care Cancer. 2018 Jun;26(6):1841-1849 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Chemotherapy-induced+nausea+and+vomiting+(CINV)+in+patients+with+advanced+lung+cancer+during+the+first-line+treatment%3A+assessment+by+physicians%2C+nurses%2C+and+patients+from+an+Italian+multicenter+survey | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Survey research | |
A Comparison of Patient-Reported Outcomes (PRO) Study Between Japan and the United States in Oncology Research: A Systematic Literature Review | ||||
Chand K;Morii J;Sato T | ||||
IQVIA Solutions Japan | ||||
Value in Health |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)32494-X/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Literature Review | |
Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story | ||||
Mpima S1, Moehler T2, Kanter S3, Mitrofan L4 | ||||
1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA | ||||
ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016. | ||||
Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3 | ||||
1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016. | ||||
Hoyer L, Schmidt N | ||||
QuintilesIMS Global Oncology, Central, East & South Europe | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK | ||||
Vega-Hernandez G1, Wojcik R2, Schlueter M2 | ||||
1 Novo Nordisk Ltd, London, UK. 2 QuintilesIMS, London, UK | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
A composite endpoint for clinical trials for new tocolytics: combining data from four U.S. integrated delivery networks. | ||||
Pimenta JM, Brinkley E, Beach KJ, Montague TH, Mack CD. | ||||
Pharmacoepidemiol Drug Saf. 2017;1–8. | ||||
Pharmacoepidemiol Drug Saf. 2017;1–8. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2017 | English | ||
Distal Fibula Fractures in National Football League Athletes. | ||||
Werner BC, Mack C, Franke K, Barnes RP, Warren RF, Rodeo SA. | ||||
Orthop J Sports Med. 2017 Sep 8;5(9):2325967117726515. eCollection 2017 Sept. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2017 | English | ||
Trends in Antibiotic Use by Birth Season and Birth Year. | ||||
Kinlaw AC, Stürmer T, Lund JL, Pedersen L, Kappelman MD, Daniels JL, Frøslev T, Mack CD, Sørensen HT. | ||||
2017 Sep;140(3). Epub 2017 Aug 14. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Finding undiagnosed patients with hepatitis C virus: an application of state-of-the-art machine learning methods. | ||||
Doyle O., Jayanti H., Homola D., Rigg J. | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/library/posters/identifying-undiagnosed-patients-with-hepatitis-c.pdf | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Finding undiagnosed patients with hepatitis C virus: an application of state-of-the-art machine learning methods. | ||||
Doyle O., Jayanti H., Homola D., Rigg J. | ||||
, Poster | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/library/posters/identifying-undiagnosed-patients-with-hepatitis-c.pdf | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2017 | English | , Predictive analytics | |
Treating iron deficiency in patients with gastrointestinal disease: Risk of re-attendance in secondary care | ||||
Susannah Tomkins, Callum Chapman, Melissa Myland, Rachel Tham, Rachael de Nobrega, Brinley Jackson, Satish Keshav | ||||
IQVIA | ||||
, Editorial | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
2017 | English | , Retrospective database analysis | ||
Linking individual-level data on diagnoses and dispensing for research on antibiotic use: Evaluation of a novel data source from English secondary care | ||||
Patrick Rockenschaub, David Ansell, Laura J Shallcross | ||||
UCL/IQVIA | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2017 | English | , Retrospective database analysis | |
Managing Privacy. The imperative RWE capability | ||||
Khaled El Emam, Benjamin Hughes | ||||
IQVIA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | , Real World Evidence | ||
Patient-Level Simulation-Based Sensitivity Analysis To Evaluate The Impact Of Under-Recording Of Underlying Comorbidities In A Retrospective Claims Database Analysis. | ||||
Zorina O1, Ferreira A1, Korn J2, Bezlyak V1, Sagkriotis A1, Skelly A1, Zangvil E1, Snow H1, Zuurman L1, Holekamp N3 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 QuintilesIMS, Burlington, Massachusetts, United States 3 Pepose Vision Institute, Chesterfield, Missouri, United States | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, 2017, Boston, MA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Privacy, Confidentiality, Security, and Ethics | ||||
L. Arbuckle, M. Chibba, K. El Emam, A. Cavoukian | ||||
Department of Pediatrics, Faculty of Medicine, University of Ottawa, 401 Smyth Road, Ottawa, Canada K1H 8L1 Electronic Health Information Laboratory, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario, Canada K1H 8L1 | ||||
Population Health Informatics, Jones & Bartlett Learning |
||||
, Book | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2017 | English | , De-identification / anonymisation | |
Real World Evidence in glaucomatous diseases: EMR data is indispensable for understanding patient journeys and optimizing care | ||||
Claudio Spera1, Yongsoo Kim1, Vladimir Bezlyak1, Alexandra Durus1, Alexandros Sagkriotis1, Fran Milnes1, Adam Gondos2, Naomi Boxall2, Tim Wintermantel2, Faisal Ahmed3 | ||||
1Novartis AG, Basel; 2QuintilesIMS, Real World Insights, Basel/ Frankfurt/ London; 3Imperial College Ophthalmic Research Group (ICORG), Western Eye Hospital, London | ||||
ISPOR 20th Annual European Congress, 4–8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, UK | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S1098301517324002 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Real-world comparison of femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: a retrospective cohort study from an outpatient ophthalmology clinic in France | ||||
Crozafon P1, Griner R2, Bouchet C3, Zignani M3, Ender F3, Keith M, Foster S4, Zou M2, Gardiner G4 | ||||
2 IQVIA, Basel, Switzerland 4 IQVIA, London, UK | ||||
European Society of Cataract and Refractive Surgerons, 35th Congress, 2017, Lisbon, Portugal |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
The Academy of Managed Care Pharmacy® NEXUS; Dallas, TX |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2017 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Phillips S, Johnson KJ, Shen SW, Woodcroft KJ, Oliveria SA, Simon TA | ||||
Phillips S: IQVIA; Johnson KJ: IQVIA (formerly); Shen SW: Bristol-Meyers Squibb; Woodcroft KJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol Meyers Squibb | ||||
American College of Rheumatology Annual Meeting, 3-8 November 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Patient Registries & Real-World Study Methods, Pregnancy | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
A retrospective study of ranibizumab treatment regimens for neovascular age-related macular degeneration (NAMD) in Australia and the United Kingdom. | ||||
Johnston RL1,2, Carius HJ3, Skelly A4, Ferreira A4, Milnes F4, Mitchell P5 | ||||